George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoss Grp. Regulatory News (RGP)

  • This share is currently suspended. It was suspended at a price of 0.5575

Share Price Information for Ross Grp. (RGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.5575
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.5575
RGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

20 Sep 2022 16:43

RNS Number : 0375A
Ross Group PLC
20 September 2022
Β 

Β 

Β 

Β 

Β 

Β 

Β 

Ross Group Plc & Subsidiaries

Annual Report and Financial Statements For the year ended 31 December 2021

Β 

For a more printer friendly version please click here

http://www.rns-pdf.londonstockexchange.com/rns/0375A_1-2022-9-20.pdf

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

LEI: 213800PIS2QRIKPZB546 ROSS GROUP PLC

Β 

Β 

Β 

Page

Company Information 1

Summary and Highlights 2

Chairman's Statement 4

Group Strategic Report 6

Report of the Directors 12

Corporate Governance Statement 15

Directors' Remuneration Report 18

Corporate Social Responsibility 19

Report of the Independent Auditors 20

Consolidated Income Statement 28

Company Income Statement 29

Consolidated Statement of Comprehensive Income 30

Company Statement of Comprehensive Income 31

Consolidated Statement of Financial Position 32

Company Statement of Financial Position 33

Consolidated Statement of Changes in Equity 34

Company Statement of Changes in Equity 35

Consolidated Statement of Cash Flows 36

Company Statement of Cash Flows 37

Notes to the Statement of Cash Flows 38

Notes to the Consolidated Financial Statements 39

Β 

Β 

Β 

Directors: B R Pettitt

S C Mehta BSc (Hons) R E Tamraz

P M Fisher

M J L D'Hombres

Β 

Β 

Secretary: S C Mehta BSc (Hons)

Β 

Β 

Registered Office: 71-75 Shelton Street

Covent Garden London

WC2H 9JQ

Β 

Β 

Registered Number: 00131902 (England and Wales)

Β 

Β 

Auditors: CBW Audit Limited Chartered Accountants & Statutory Auditors 66 Prescot Street London

E1 8NN

Β 

Β 

As we have previously reported in our interim accounts, during the first half of 2021, Ross Group Plc ("RGP") has been having to go through the process of restructuring its acquisition of the four start-up businesses that were completed in 2019 and which are wholly-owned subsidiaries within Archipelago Aquaculture Group (AAG) and had amongst other things been primarily subjected to the Worldwide consequential effects of the COVID Pandemic.

Β 

This is therefore the first full year RGP Annual Report that includes and consolidates the AAG's results, particularly given the above COVID circumstances.

Β 

As a result, there is a fundamental difference in the 2021 results in comparison to its previous year.

Β 

RGP has, for many years now, been operating based on a specialist professional supply chain management model and continues to do so to date. However, the AAG acquisition subsequently caused that model to have to be modified; in order to include and integrate other more specialist supply chain services and functions, particularly with regard to the requisite research and development ("R&D") in order to try to provide proof of pioneering production concepts and then thereafter transition at a considered viable point in the future into mass production and sales of product and/or global turn-key projects of hopefully high quality pharmaceutical grade Chitin.

Β 

For our fiscal year 2021, no services or sales of Chitin were able to be recorded - as all of the R&D and implementation of pioneering production processes were more than hampered by both restricted and/or reduced funding from the seller of the AAG businesses, in combination with the commercial effects of COVID causing the operations to have to be indefinitely suspended whilst a review and remedial restructuring took place; resulting in the renewed and continued Chitin focus through a new venture, namely, RGP-525.

Β 

Production and administration costs have been subsequently subjected to specific strategic reorganisation, which has resulted in the further impairment and/or reduction of certain contingent, capitalized and considerable pre-existing liabilities that the AAG companies were incurring both in advance of any production and with all the logistical labour constraints of COVID. The relocation and centralization of the venture allows for a much more manageable and efficient operation and overhead structure once a post-Covid norm can be established.

Β 

Β 

Your Board of Directors had initially always anticipated and estimated that it would take a considerable amount of time and funding in order to get this new technology into mass production and had initially provisioned for it accordingly. However, the commercial confluence of COVID and the consequential cashflow constraints, caused by the lack of the pre-agreed financing from the seller of the AAG business were both exceptionally unique and unpredictable.

Β 

Our new venture, RGP-525, with the founder of 525 Solutions, Professor Robin Rogers, who had previously sub-licensed their proprietary ionic liquid extraction technology, has provided us with a more viable, cost-effective, supply chain solution that enables making the best out of a bad set of circumstances. The Group will also continue in its endeavours to strategically search for suitable synergistic partners and opportunities.

Β 

Throughout this post-acquisition and COVID pandemic period, there have been considerable costs incurred during development and/or downsizing of all of the start-up AAG businesses and management has been extremely diligent in ensuring that such initial and consequential costings are to now be commensurate with real-time performance criteria and actual achievements, especially given the ensuing effects and constraints of COVID and limited financing calling for a more conservative approach.

Β 

Β 

Therefore, wherever possible and/or necessary, the Group's specialist supply chain management experience has been highly re-focused upon implementing newer strategic disciplines, procedures and protocols in order to try to provide the best possible performance in its endeavours over time; hence the consideration and approval by the Board to the RGP-525 new venture as an investment holding, thus enabling the Group to seek out other opportunities, preferably potentially start-up and pre-financed in a more strategically secured structure.

Β 

The resulting loss for the year was Β£2.576m (2020: Β£1.245m) which duly reflects the respective restructuring, working capital costs and expenses to date.

Β 

Β 

Β 

2021

2020

2019

Β£ 000's

Β£ 000's

Β£ 000's

Restated

Restated

Revenues

-

43

-

Other income

6

136

14,502

Total costs

(2,582)

(1,424)

(17,441)

────

────

────

(Loss) for the year

(2,576)

(1,245)

(2,939)

════

════

════

Β 

It is once again my pleasure to report to you on both the business activities and the financial results of the Ross Group Plc for the financial year ended 31st December 2021.

Β 

Having endured the unprecedented occurrence of COVID and a number of consequential as well as also some unrelated challenges, we are pleased and proud to announce that your Board has been able to respond as best as possible through taking diligent and prudent measures accordingly.

Β 

In addition, the Group is still actively deploying our specialist supply chain management services on a project-by-project basis and we are also, particularly at present, evaluating several strategic start-up opportunities that given a post-COVID pandemic period are believed to be worthy to explore.

Β 

Since becoming Chairman, over 10 years ago, I have always been mindful - even while our Board of Directors were constantly busy with such exploratory work - that our operating businesses and Premium Listing Company status should always be capable of generating sufficient profit and/or cashflow in order to primarily cover running costs of the business on a potentially worst-case scenario. Therefore, through these exceptionally unusual COVID years we have had to rightfully reorganize and incur such significant restructuring expenses - which are considered to be reasonable given our previous many years of careful and conservative costings.

Β 

In this respect, our 2021 result of a Β£2.576m loss (2020: Β£1.245m loss) is considered by the Board to be both understandable and justifiable under such circumstances.

Β 

There was no revenue in the year. Costs have increased over 2020 and relate predominantly to various restructuring, operational, accounting and legal costs.

Β 

Β 

The Board and myself remain satisfied with the ongoing progress that we have made over this last year's cumulative challenges by identifying, initiating, and implementing our respective emergency and/or restructuring strategic plans.

Β 

We will continue to be prudent and focused in our specialist supply chain service management and also our Board remains conservatively confident that we will be able to progressively focus in on identifying and being able to put forward an appropriate refined start-up strategy of opportunities for the Board to consider and to hopefully be able to then present to our Shareholders at some stage in the foreseeable future.

Β 

Regarding the continuing subject of Brexit, given our domiciled departure from the EU, the timing, terms and impact of the United Kingdom's exit are still considered difficult to predict; especially with the combined confluence post-COVID and also the recent predictive effects of the Ukrainian-Russian conflict. Regardless of the anticipated time scale, terms and conditions of the United Kingdom's exit from the European Union, the result with regard to these political and economic events provides an outlook where it is anticipated that there may be some volatility on the exchange rate between the Pound Sterling ("Β£") and the Euro ("€") and more generally, between the Β£/Pound and other international currencies such as the US Dollar ("US$").

Β 

Because some subsidiaries are presently based both in the United States and/or also outside of Europe, they are therefore predominately in a US$ currency environment and while this could lead to adverse consequences in terms of US$/Β£ exchange rates, our respective subsidiaries and/or joint ventures are not yet fully trading or selling products, and therefore we do not anticipate any material negative impact and do not intend to take specific measures to cover fluctuations of the currency market at this stage.

Ross Group Plc & Subsidiaries Chairman's Statement

For the year ended 31 December 2021

Β 

Β 

Β 

As always, I would like to particularly personally thank our Board of Directors, our specialist contractors, consultants and advisors, for all their excellent support, commitment and hard work in helping the Group wherever possible towards achieving its aims.

Β 

Again and again, I would also like to personally thank our extraordinary loyal shareholders for their continued patience, understanding and support during this extraordinary period in time.

Β 

Β 

Sincerely

Β 

Β 

Β 

Barry Richard Pettitt

Chairman & Group Managing Director Ross Group Plc

Date: 2022

Β 

The Directors are pleased to present their strategic report of the Group and the Company for the year ended 31 December 2021.

Β 

Background and History

The existing management team that took over control of the Ross Group Plc approximately thirteen years ago has been consistent in their prime objective to search for suitable supply chain start-up opportunities in order to try to build a balance of businesses that would be commensurate with the respective existing and potential value of the Group's Premium Listed Main Board status and, as a result, would also enable the Group to be able to potentially enter into more mergers and acquisitions in the foreseeable future, whenever deemed appropriate, that in turn could create a sizeable, stable and potentially prosperous long term enlarged Group going forward.

Β 

Business Strategy: 2022 Model & Principal Activity

During 2020, Ross Group Plc's Archipelago Aquaculture Group ("AAG") entered into a new venture with 525 Solutions ("525"), a company that was founded in 2015 by Professor Robin Rogers, who created, co-patented and licensed the Ionic Liquid extraction process that was initially exclusively sub- licensed by AAG and who together in 2018 they had respectively collaborated together to be able to win the USA environmentally prestigious EPA Green Chemical Award. Given the constraints of COVID together with an unexpected reduction of pre-agreed R&D financing, a more refined restructuring strategy was required, It was therefore the considered opinion of both Ross Group Plc and 525 that as this Ionic Liquid extraction process has never yet been mass produced to such a high grade quality and quantity, there could be significant synergies in collaborating together in a collaborative strategic new venture,

in order to try to successfully attain such a World class, ground-breaking achievement. Therefore, in 2021, RGP-525 - albeit under unique and challenging COVID circumstances - was duly created and has endeavoured to continue to further its research and development as a separate business unit, in which the Group has a 19.9% investment holding, thus enabling Ross Group Plc to maintain its prime objective to re-focus to search for other suitable supply chain management opportunities in order to try to build a balance of businesses that would be commensurate with its respective existing and/or potential value as a Premium Listed Company on the Main Board of the London Stock Exchange.

Β 

Business Review 2021

The Group as at 31 December 2021 consisted of Ross Group Plc and three wholly owned subsidiaries; Ross Diversified Trading Limited ("RDT"), Ross Group Plc Inc. and Archipelago Aquaculture Group LLC ("AAG").

Β 

AAG continues to contain the start-up businesses of Mari Signum Limited, Mari Signum Dragon Drying- MS LLC, Mari Signum Mid-Atlantic LLC and Prometheus Progenitor Genetics Technologies Limited LLC - all having been initially involved and integrated within the main Chitin-based business of AAG.

Β 

These subsidiaries have strategically been operationally restructured in favour of combining certain Chitin corporate assets and equipment with those of 525 Solutions (a company founded by Professor Robin Rogers, who is the collaborative creator of the ionic liquid extraction process for Chitin) and, in doing so, forming a new venture, RGP525 Solutions LLC, in which AAG has an investment holding of 19.9%.

Β 

Whereas the main focus of the Board, throughout the last decade and to date is to consistently continue to explore various promising start-up or existing business opportunities around the World, it is envisioned that through our restructuring efforts in 2021 the ability for us to re-focus on these new endeavours in 2022 should help enable us to be able to provide further opportunities for consideration in the near future.

Β 

Regarding the Group's revenue performance in 2021, while undergoing the continued restructuring of the Group during the constraints of COVID and restricted cashflow, all operations were either suspended and/or wound-down respectively in favour of the RGP-525 new Venture with 525 Solutions, along with a further restructuring of AAG in order to accommodate a more enhanced, efficient and effective separate business unit strategy.

Β 

The Directors are confident that, given its reasonably resolute structure and strategies, the underlying value of the Group should be able to remain strong and that the Group will hopefully find success in securing the strategic business that it is currently seeking.

Β 

Regarding the financial position at year-end 2021, the Board can report that the Group's statement of financial position shows that through such restructuring efforts total assets are Β£394k compared to

Β£1,449k in 2020.

Β 

It is also worth noting that, in prior years, one of the largest items in the Group's balance sheet was the long-term "Interest-bearing loans and borrowings" of Β£6.072m that has since been restructured into Convertible Loan Debentures, which were approved by the Board and Shareholders accordingly in 2020 and have been subsequently restructured in 2021 and extended for up to a further one to three years (at the Board's discretion) potentially until 2025. Thus the Group has managed to maintain a relatively healthy cashflow position through the diminishment of this liability and also by the issuance of new shares.

Β 

Business Outlook

The Board is reasonably confident, notwithstanding the COVID Pandemic and its subsequent ongoing economic effects, that there will still be various unique and exciting opportunities ahead - particularly in the short-term - for its business to be sustained and/or transformed for potential growth to be considered in the future.

Β 

As at the reporting date, the Group held Β£209k in cash, total assets of Β£394k and current liabilities of

Β£3,875k, including amounts owed to associated undertakings of Β£2,335k.

Β 

Contemplation of cancelling all deferred shares, resulting in a one-off exceptional gain, is currently under consideration by the Board in order to provide a platform for future investment opportunities.

Β 

The budgets and cashflows set for 2022 & 2023 given ensuing partial COVID Pandemic provisions, indicate that there are sufficient working capital reserves, especially given prudent provisions.

Β 

Β 

Economic Considerations

In the light of the ongoing COVID pandemic and the uncertainties this brings, the Directors have also prepared cashflow forecasts to December 2023. These cashflows have been sensitized to assess the adequacy of cash available should further COVID restrictions, global fuel prices, recession and/or inflation impinge the activities of the Group. Based on the sensitivity testing and additional resources available the directors are satisfied the group can continue as a going concern for the foreseeable future.

Β 

Due to the emergency measures implemented by the respective Governments, which are still ongoing in certain respects, and also given the subsequent strategic RGP-525 new venture regarding the development cycle of Chitin, the Group has already taken prudent steps to minimise the cost exposure of its activities accordingly.

Β 

The Group is regularly reviewing its initial projections and also aiming to minimise any potential deficits over the next financial year by trying to reduce all non-essential expenditure.

Β 

Section 172(1) Statement

Β 

Within the strategic report for this financial year is the mandated Section 172(1) Statement which hereby describes how the Board of Directors have acted in regard to the matters set out in Section 172(1)(a) to (f) when performing their duties under this Section.

Β 

These duties have included, but are also not necessarily limited to, their responsibility to earnestly promote the success of the Group and its companies, to act in the way that he or she considers to be in good faith and would be most likely to promote the success of the Group and its companies for the benefits of its shareholders as a whole, and other stakeholders.

Β 

The Directors welcome the opportunity to also engage with our shareholders and other stakeholders, wherever possible, in promoting and discussions regarding reasonable, non-price sensitive information on subjects that are only available within the Public Domain.

Β 

In both the Chairman's Statement and in this Strategic Report, the Chairman and directors have detailed the matters affecting the Group during the year particularly the subsequent restructuring of AAG.

Β 

The acquisition of AAG during 2018/2019 together with the effects of COVID, a reduction of pre-agreed financing from the seller of AAG and ongoing restructuring implementation have had significant impacts on the Group and have subsequently resulted in a consecutive loss for the year.

Β 

The details given in these reports, particularly on pages 6 & 7, outline the Directors strategy for the business both in the short and the longer term.

Β 

The main factor facing the Directors is the ongoing financing of the group and/or any impact that the COVID-19 pandemic may have on the business. These matters have had due consideration by the directors and are detailed in the Strategic Review, in the Business Review 2021, Business Outlook and Corona Virus pandemic considerations on pages 6 & 7 and Principal Risks and Uncertainties on page 9.

Β 

At the end of last year it was reported that there was only one employee (excluding the directors) remaining at the year-end (none UK) and that employee is now on a part-time employment. During the current year more employees had joined the group as the previously dormant subsidiary, Ross Diversified Trading Limited had now become more active, however, it has since been decided to restructure their employment, respective roles and responsibilities while also considering other opportunities that may perhaps be presented by them and/or other parties in the foreseeable future.

Β 

The main stakeholders are the shareholders and the directors are committed to acting in their best interest and communicate to them at the AGM and through regular correspondence and/or webinars, whenever deemed relevant, as well as through timely filing of informative interim and year-end financial statements, stock exchange announcements and as detailed in the Governance Report on page 12.

Β 

As detailed in the Strategic Report on pages 6 to 11 the directors are proud of the Group's Premium Listing on the Main Board of the London Stock Exchange and therefore always have the desirability of the Group and its companies maintaining a reputation for high standards of business conduct as also detailed in the Governance Report on page 15.

Β 

As the Group is continuing to be focused on research and development through its relationship in the RGP-525 new venture with 525 Solutions and the key relationship with Professor Robin Rogers, it can confirm that there is little or no impact that the Group has on its community or environment as detailed on page 10 of the Strategic Report.

Β 

Whilst the Group has sufficient cash and reserves to meet its current needs as detailed in the Strategic Report on page 7, the directors are always striving to increase revenue and raise funds for strategic opportunities they view are beneficial to the Group shareholders.

Β 

Principal Risks and Uncertainties

Notwithstanding the Coronavirus Pandemic, the main risk to the existing operations of the Group is the possibility of depleting necessary working capital. The Board is both fully aware of these risks and, as a result, has always endeavoured to managed its cash and cashflow as conservatively and prudently as possible; ensuring that its exposure to any RGP-525 liabilities in this instance are primarily limited to its initial investment.

Β 

Due to time constraints the company has not been able to publish the 2021 accounts before the deadline of 30 June 2022. As a result of this the trading of the company's shares has been suspended on the London Stock Exchange. It is understood that this suspension will be removed when the financial statements are published.

Β 

In addition, the Board is equally endeavouring to ensure that funds are being made available to the Group, through the issuance of new shares and/or other financial instruments, whilst also exploring other opportunities for future growth.

Β 

Your Directors are therefore reasonably confident that the Group currently has both the financial resources and capability to fund existing expenses for future growth.

Β 

Viability Statement

The Group's business activities, together with the factors likely to affect the future performance and position are set out in the Group Strategic Report and Going Concern Statement on pages 6 to 11

Β 

Having endured a protracted period of the COVID Pandemic over the last 2 years, the Group has now begun to take a longer term view of various post-COVID Pandemic potential factors, ranging from Global and/or Continental inflation and recession, through to perhaps other opportunities arising in such markets, for example, in Crypto exchanges and/or Supply Chain Management (SCM) services.

Β 

Given the current listing of the Group on the Main Board of the London Stock Exchange and also it's present Premium Listing status, both of which individually and/or collectively are of considerable value, the Group believes that it is in a viable position to be able to enter into either possible start-ups, joint ventures, mergers and/or acquisitions; any of which would probably involve an injection of new management and business(es) that could transform the Group significantly.

Β 

In addition, the Group's existing business potential is presently beginning to take shape in its commodity-based trading and supply chain management services; with initial contracts being forecasted and/or envisioned accordingly.

Β 

As recently demonstrated, new share issuances have been successfully placed to date and there seems to be a continued interest for possible or potential further new share issuances in the foreseeable future.

Β 

Breakdown by sex of directors

At 31 December 2021 there are five directors: five men and no women.

Β 

Β 

Environmental matters

Β 

1 - UK Companies

In the year under review, the activities of all of the RGP UK companies (Ross Group, the parent) and Ross Diversified Trading (a subsidiary) involved no direct manufacturing, mining or materials processing. The UK based Directors mostly worked from home, made frequent use of telecoms/remote conferencing to discuss company business and occasionally met at hired premises.

Β 

The Board considers that in such circumstances, the carbon emissions arising from those Directors' activities (excluding the Chairman) are minimal.

Β 

The Chairman, Mr Barry Richard Pettitt who in the past has previously travelled extensively around the world, accompanied occasionally by other directors, had in fact not travelled internationally at all during 2020 however he has started to travel more extensively in 2021 in pursuit of new opportunities. Therefore, the total number of business miles the Ross directors travelled in 2021 is calculated at 44,443 which, per the conversion factor taken from the Carbonify.com, website amounts to 23.2 kg CO2.

Β 

2 - US Companies

The acquisition of AAG in January 2019 meant that the Group now had for the first time in many years research and development facilities with industrial processing/manufacturing premises. Given aforesaid circumstances, these were restructured accordingly, as discussed elsewhere in this report, so that the commercial production of Chitin - a powerful, natural polymer containing characteristics with the potential to alter industries and improve the environment - now forms an integral part of a new venture, namely, RGP-525 which intends to use its best endeavours to produce market-ready, premium quality Chitin in an environmentally conscious manner at some time in the future. This investment is being monitored and managed through Ross Group PLC Inc., which is also responsible for the Group's other USA investments and activities. All US Companies have managed to maintain a minimal number of employees and/or sub-contractors.

Β 

The Board of Directors are very proud to be partly responsible for such an environmentally friendly new venture operation and subsidiaries that are also, wherever possible, committed to similar standards, ethics and governance.

Β 

Β 

The Board of Directors, who are responsible for the day-to-day management of the Group, have considered the requirements of the FCA new Listing Rule to enhance climate- related financial disclosures for periods beginning on or after I January 2021 and the associated recommendations of the Task Force on Climate Related Financial Disclosures (TCFD).

Β 

The TCFG recommend disclosures are made specifically in the areas of governance and risk management with regard to climate related risks and opportunities and where material the strategy and metrics and targets used to assess such risks and opportunities.

Β 

The Board at their regular meetings consider all risks and opportunities facing the Group. The current limited operations of the Group, in the judgement of the Board, do not give rise to significant risks and opportunities related to climate - related matters and the Board have therefore not fully made all disclosures consistent with the some or all of the TCFD's recommendations and / or recommended disclosures on the grounds of materiality.

Β 

The Board at regular meetings, from a governance perspective, has continued oversight of operations, they consider any climate -related matters that may arise from changing activities and any risks or opportunities that may arise. These matters are considered for the short, medium and long-term impact they may have and the Board continues to strive to support a low carbon economy.

Β 

Β 

Β 

From a risk management perspective any opportunities being considered by the Board must also highlight as part of that due diligence any risks associated with the opportunity. The impact any climate- related matters may have resulting from its location, changing climate conditions we are seeing develop that may impact the future of such an opportunity be it from rising temperatures resulting in flood, fire, rising sea levels or such other climate - related matters, climate related policy or emerging technologies. The risks are not only considered from the Group's perspective but from that of our supply chain and customers also. The Board consider the impact any such risks may also have on our ability to raise future capital or restructure debt should that be required.

Β 

There are no such climate -related risks identified at this time and the possible opportunities being considered by the Board be it through the investment in RGP-525 or other opportunities under consideration do not give any additional climate - related risks.

Β 

Β 

On behalf of the Board

Β 

Β 

Β 

…………………………………… Barry Richard Pettitt - Chairman

Date: 2022

Β 

Β 

The directors present their report with the financial statements of the company and the group for the year ended 31 December 2021.

Β 

Dividends

No dividends will be distributed for the year ended 31 December 2021.

Β 

Events since the end of the year

Information relating to events since the end of the year is given in the notes to the financial statements.

Β 

Directors

Β 

B R Pettitt (Chief Executive Officer)

Barry Richard Pettitt, aged 62, was appointed to the board on 22 December 2008 as the CEO of the group and elected as its Chairman and CEO on 28 April 2009. He has more than 30 years' experience within the consumer electronics and supply chain management industries, during which time he successfully started a specialist supply chain management services company. ISO International (Holdings) Ltd, which was subsequently purchased by a Hong Kong Public Company for HK$ 155,000,000 in 2003. In addition, he has managed a number of Public Company divisions (in the capacities of President and Managing Director) and successfully relisted a Hong Kong Public Company, Vision Tech Ltd, as its CEO in 2007. Prior to that, he was the joint Managing Director of Ross Consumer International Ltd and a main board director of the Ross Group (formerly Ross Consumer Electronic Plc) in 1987 after which he has continued to be a shareholder in Ross Group for the last 34 years.

Β 

S C Mehta (Executive Director)

Shashi Mehta, aged 64, was appointed on the board on 22 December 2009. He holds a BSc (Hons) in Manufacturing and has had a distinguished career in a variety of industrial and manufacturing trouble- shooting roles. He brings a wealth of experience and expertise to the Group. He spent many years working for the Ford Motor Company, and was Operations Manager in Ross Consumer Electronics during the 1980's.

Β 

R E Tamraz (Non- Executive Director)

Roger Tamraz aged 81, was appointed to the Board in December 2020 as a Non-Executive Director. He is an international banker and venture capital investor who has had an active business career in banking, oil and gas spanning from Middle East to USA. Fluent in English, French and Arabic, he was Chairman of Kidder, Peabody & Co. Middle East. Also has owned and controlled banks in the Middle East and in the United States; Also, having led the takeover and then re- built the largest bank in Lebanon, Intra Bank.

Β 

P M Fisher

Philip Fisher aged 68, was appointed to the board in February 2021. He was the joint Managing Director of Ross Consumer International Ltd., a subsidiary of Ross Group (formerly Ross Consumer Electronic Plc) in 1988/89 and has since maintained an excellent working relationship with its senior management for many years. He will oversee new business divisions and/or developments within the UK.

Β 

Newly Elected Directors

Β 

M J L d'Hombres (Non- Executive Director)

Marc d'Hombres aged 75, was appointed to the board in December 2021 as a Non-Executive Director. He is a loan and economics graduate from Paris university and has in-depth experience managing boutique investment banks and private equity funds. He is well versed in the African markets and an expert in trade and project financing.

Β 

Financial Instruments

Details of the financial instruments used by the group can be found in note 22 of the accounts.

Β 

Employee Involvement

During the year there was an average of 3 employees, and 5 Main Board directors.

Directors Interests Directors

Mr Barry Pettitt has from time to time entered into contracts with Ross Group concerning the provision of professional services to third parties and/or subsidiaries. Apart from this, no director had any interests in contracts of significance with the company.

Β 

In accordance with the Articles of Association members will be asked to confirm the appointment of all directors.

Β 

The total number of shares controlled by Barry Pettitt, directly and indirectly through Lynchwood Nominees Limited (previously Prime Growth Enterprises Limited) at the date of this report was 27,305,609 (11.72%). Mr Pettitt has sought and obtain Board approval to specifically negotiate and possibly increase his shareholding interests as well as to further his loan position with Group on existing financial instruments

Β 

Substantial shareholdings

As at 31 December 2021 the following were registered as being materially interested in 4% or more of the company's issued share capital, or being a related shareholder.

Β 

No of Ordinary Shares

% of Issued Share Capital

Keniworth Capital Limited

40,000,000

17.17%

Vidacos Nominees Limited

37,033,448

15.89%

Lynchwood Nominees Limited Des: 2006442

27,078,369

11.62%

Escalating Investments Limited

22,200,720

9.53%

Β 

Statement of Directors' Responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Β 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with International Financial Reporting Standards as adopted by the UK and the Republic of Ireland. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

Β 

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- state whether applicable UK Accounting Standards have bene followed, subject to any material departures disclosed and explained in the financial statements;

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

Β 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Β 

Directors' Responsibility Statement

We confirm that to the best of our knowledge:

Β 

1. The financial statements, prepared in accordance with International Financial Reporting Standards as adopted by the UK and the Republic of Ireland, give a true and fair view of the assets, liabilities, financial position and profit or loss of the company and the undertakings included in the consideration taken as a whole; and

Β 

2. The management's report, which is incorporated into the Directors' Report together with the information provided in the Chairman's Statement, the Strategic Report, includes a fair review of the development and performance of the business and the position of the company and the undertakings included in the consolidation as a whole, together with a description of the principal risks and uncertainties that they face.

Β 

Statement as to disclose of information as Auditors

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

Β 

Auditors

In accordance with section 485 of the Companies Act 2006, a resolution proposing that CBW Audit Limited be re-appointed will be put at the forthcoming Annual General Meeting in 2022.

Β 

Β 

On behalf of the Board

Β 

Β 

………………………….. M J L d'Hombres Director

Date: 2022

Β 

Application of The Principles of the UK Corporate Governance Cod

Β 

The group is pleased to present its report on Corporate Governance and the UK Corporate Governance Code. The board strives to comply with the high standards set by the UK Corporate Governance Code as incorporated in the UK Listing Rules of the Financial Conduct Authority. The Code requires the company to make a two-part disclosure statement, firstly on how the principles of the code are applied and secondly confirmation of compliance or explanation of any reason for deviation from the Code. Throughout the year the company has complied with the main principles of the Code.

The Board

There is an effective and appropriately constituted board which in the year under review consisted of five directors. The Chief Executive, Mr Pettitt who is normally based overseas, also serves as Chairman. The board is fully aware that this is contrary to Code provision A.2.1, which states that the roles of chairman and chief executive should not be exercised by one individual. The board is of the opinion that, given the current size of the business, and also Mr Pettitt's undoubted and considerable knowledge, experience and contacts in the Group's field of operations that the shareholders' interests are best served by this arrangement. The board is active in its management of the group and meets and confers regularly on business matters arising. These frequent and robust discussions serve to ensure that no one individual has unfettered powers of decision.

During 2021 Mr Pettitt was supported by four other directors: Mr P.M. Fisher being appointed in January 2021 and Mr M J Simon, who was appointed in April 2009 and retired in December 2021, Mr S C Mehta who was appointed in December 2009, and Mr R Tamraz being appointed in December 2020.

Β 

Mr Simon who acted as company secretary since April 2009, resigned on 14 September 2022. Mr S C Mehta was appointed as the company secretary on 14 September 2022.

Β 

One director resigned from the board in December 2021 Mr M J Simon. One new director was appointed December 2021 Mr M J L D'Hombres.

The two non-executive directors, Mr D'Hombres and Mr Tamraz, are considered to be independent as there are no circumstances or relationships as described by Code provision B.1.1 which apply to their appointments. The group's definition of a non-executive director is one who considers the interest of all the shareholders and this is demonstrated during the board meetings. As part of their role, the non- executive directors constructively challenge decisions and help develop strategies and plans for the benefit of the board.

Board procedure

The board is responsible for decisions concerning strategic and financial planning and matters involving the overall direction of the company. Management will seek board approval of the annual budget and rolling business plan. Reforecasts are presented as updates to the budget throughout the year to account for variances and provide forward vision. The operational business decisions are taken by local management with reference to the board where necessary.

Β 

The board has established several separate committees for the following: Appointments (Chaired by Mr Pettitt);

Audit & Remuneration (Chaired by Mr D'Hombres); Governance & Compliance (Chaired by Mr Mehta)

Β 

All of the directors are subject to periodic re-election and also the full board considers all appointments. A director will require re-election within a maximum period of three years.

Biographies of the board are included in the financial statements. These indicate a wealth of experience, which is essential in effectively managing the activities of the group. In addition to this the board members, wherever deemed appropriate and/or possible, endeavour to attend relevant seminars and courses of their respective professional organisations.

Β 

Attendance

Board meetings are held regularly throughout the year. Due to the location of the directors, the meetings are often held electronically. The board is supplied with all the information relevant to the meeting in a timely manner and in a form and quantity appropriate to enable it to discharge its duties during the meetings.

Β 

The board has now established procedures in respect of access to the company secretary and the directors have access to consult the company secretary when required.

Β 

All shareholders have the opportunity to put forward questions to the board during the company's Annual General Meeting and the board communicates with the shareholders via the notices and other papers relating to the Annual General Meeting. The company also welcomes and responds wherever possible to communication, preferably in a written form, from its Shareholders regarding reasonable, non-price sensitive information requests on subjects that are only available within the Public Domain.

Β 

The company website allows shareholders to contact the directors by email.

Β 

The board has carried out a formal and rigorous annual evaluation of its performance and of its committees and individual directors. This evaluation covers contribution, commitment and the manner in which board related duties have been completed. The chairman has discussed the review with individual directors where necessary to ensure the board operates as an effective unit. The performance review was conducted using recognised evaluation processes. The independent non- executive director has conducted a performance review on the chairman which included the consideration of the views expressed by the executive directors.

Β 

Internal audit and control

The respective responsibilities of the directors and the auditors in connection with the financial statements are set out in the audit report. The directors have overall responsibility of the effectiveness of the group's whole system of internal control, including financial and other controls, which are designed to provide reasonable but not absolute assurance against material misstatement or loss. The key procedures that the directors have established to provide effective internal financial control are as follows:

Β 

Financial Reporting

There is a comprehensive system for reporting performance. During the course of the year, a one year rolling budget is prepared for each company within the group and a consolidated budget is prepared for the whole group. The board then formally approves the budgets. The results are then reported regularly to the board for their consideration and forecasts are revised accordingly.

Β 

Quality and Integrity of Personnel

The integrity of the group is maintained through the appointment of experienced and professional staff and the application of appropriate policies and procedures.

Β 

Capital Investment

The group has set procedures for capital expenditure. These include annual budgets, appraisals and review of the required expenditure, approvals at the right levels of authority and the commissioning of independent professional advice where appropriate.

Β 

Professional Advice

Professional advice is usually sought on contentious and disclosure issues, this being as a result of discussions during the Board Meetings. During the year the Chairman can seek independent professional advice in relation to matters affecting the group.

Β 

The group has an ongoing system for identifying, evaluating and managing the significant risks faced by the group which has been in place for the whole of the year under review up to the date of approval of the annual report and accounts and which is regularly reviewed by the board to ensure it continues to accord with the UK Corporate Governance Code. The directors have reviewed the effectiveness of the system of internal financial control during the year from information provided by the management and the group's external auditors. It must be recognised that such a system can only provide reasonable and not absolute assurance, and in that context, the review revealed nothing which, in the opinion of the directors, indicates that the system was inappropriate or unsatisfactory.

Β 

The group has no formal internal audit function and the board has determined that there is no need for one. The board considers that internal audit is dealt with in other ways and the situation is regularly reviewed.

Β 

Going Concern

The directors confirm that after making the appropriate enquiries, they are of the opinion that the group as a whole has adequate resources to continue in operational existence for the foreseeable future and therefore have prepared the financial statements on a going concern basis.

Β 

External Audit and Audit Committee

The Audit Committee during 2021 comprised of the non-executive directors, Mr Simon and Mr D'Hombres, as well as Executive Directors Mr Mehta and Mr Fisher. The committee was chaired by Mr Simon until 31 December 2021 when this role was passed to Mr D'Hombres. It met periodically to review the adequacy of the group's internal control systems, accounting policies, corporate governance policies and compliance with applicable accounting standards and to consider the appointment of the external auditors and to review their fees. CBW Audit Limited is invited to attend these meetings. The Audit Committee is authorised by the board to investigate any activity within its terms of reference and obtain external professional advice as is necessary.

Β 

Β 

By order of the Board

Β 

Β 

Β 

……………………………….. Barry Richard Pettitt

Chairman & Group Chief Executive Officer Date: 2022

Β 

The board is pleased to present its remuneration report in accordance with section 12.43A(c) of The Listing Rules.

Β 

The board has in place a remuneration committee, comprising Mr Michael Simon, non-executive director to 31 December 2021, and Mr B Pettitt, Chief Executive, to determine the remuneration of the board. Post year end Mr Tamraz joined the committee following Mr Simon's resignation.

Β 

The company policy during the restructuring period throughout 2021 was to continue to pay directors only a nominal Β£1 salary (which has been in place since 2008). This policy will be reconsidered as occasion arises and as the new business opportunities open to the group are realised. The directors feel it would be inappropriate to take any reward until that has been achieved.

Β 

Β 

Β 

Name

Β 

Β 

Position

Β 

Gross salary

Β 

Β 

Benefits

Β 

Notice Pay

Total

Remuneration 2021

Total

Remuneration 2020

B R Pettitt

Chairman/ Group Chief Executive

Β£1

Nil

Nil

Β£1

Β£1

M J Simon

Non- executive Director

Β£1

Nil

Nil

Β£1

Β£1

S C Mehta

Executive Director

Β£1

Nil

Nil

Β£1

Β£1

R E Tamraz

Executive Director

Β£1

Nil

Nil

Β£1

Β£1

P M Fisher

Executive Director

Β£1

Nil

Nil

Β£1

Β£1

M J L D'Hombres

.

Non- executive Director

Nil

Nil

Nil

Nil

Nil

Β 

No director currently has a service contract with a notice period in excess of 12 months. All executive directors have contracts that require a notice period of one month. The contracts of the non-executive directors would normally be renewed for a period of one year. All directors are presented for re-election by the members at the Annual General Meeting on a maximum cycle of three year.

Β 

The group does not currently operate a director's share option scheme or a long-term incentive system. The group also does not currently have an employees' share scheme or other long-term incentive.

The board has instructed local management to ensure the companies address those corporate social responsibilities which are recognised as being of prime importance. The responsibility for CSR rests with the Chief Executive Officer, Barry Pettitt, who will bring to the board's attention any major issues which require their approval and regularly updates the board on CSR matters. The views of shareholders and interested external parties are considered when developing the ongoing policy to CSR.

Β 

Figures are available for the board to review to enable them to assess the trend towards improvement in CSR matters and to direct the policy towards those areas that require further attention.

For the year ended 31 December 2021

Β 

Β 

Employees

For several years the only employees of the company were its directors. This changed with the acquisition of AAG in January 2019. When this happened, the Group inherited 25 employees, this has now reduced on the reorganisation of AAG.

Β 

The group has always taken the view that employees constitute a group's most valuable asset and therefore it has always been committed to ensuring they should enjoy the best environment in which to perform their duties, one of equal opportunity and free from discrimination and harassment.

Β 

For reasons discussed elsewhere, it was not possible to continue operations with the four businesses of AAG constituted as they were, and those facilities during and by the year ended 2019 were suspended. Consequently, at the year-end 2019 there was only one employee left on the payroll of the AAG companies. During 2021 this has increased to three and they have been joined by three new employees in Ross Diversified Trading Limited as this, previously dormant subsidiary commenced trading in the year 2020. In 2021 trading results proved difficult and numbers have been reduced again.

Β 

The group strongly believes in the future of the AAG technology, and we have developed a corporate structure to facilitate that development through the RGP-525 new venture. We will aim to promote a culture which suits the recruitment and retention of the highest calibre of staff and to ensure that all staff will be trained to the appropriate standard required to fully meet their job specifications.

Β 

The health and safety of the employees is paramount to the group. Staff are issued with data sheets on the handling of any substances which might be toxic and will be trained in the correct procedures to follow. Any potential issues can be raised with Mr Pettitt.

Β 

Environment

The board is fully aware of its responsibilities and fully supports the drive for ongoing improvement in this area. The impact the group's activities on the environment are regularly assessed to enable action to be directed at areas where any harmful impact could be reduced. As noted above the travel and energy use in the group have been limited over the past two years.

Β 

The group has worked with its suppliers during the year to ensure the products used in manufacturing and any waste arising from the use of those products have a minimal impact on the environment. The use of energy is closely monitored, and the available controls are used to good effect to reduce consumption where possible.

Β 

Customers

Customer satisfaction is one of the main targets for the group and this is aided by a rigorous quality policy. The Quality procedures adopted by the group require the recording of customer feedback and measures our performance against customer expectation. The group strives to meet the demands of its customers, but also ensures that solutions to their requirements are designed with efficiency.

Β 

Local Community

The group seeks to inter act with the local community and develop close relationships within its area of operation. It has established links with the local schools and colleges.

Β 

Commitment

The group will continue to enhance its approach to CSR to ensure that it supports the principles as it expands its range of activities and welcomes any suggestions on how it can improve in this area.

Β 

Opinion

We have audited the financial statements of Ross Group Plc (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2021 which comprise the group and parent company's Income Statements, Statements of Comprehensive Income, Statements of Financial Position, Statements of Changes in Equity, Statements of Cash Flows and notes to the consolidated financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the United Kingdom.

Β 

In our opinion the financial statements:

- give a true and fair view of the state of the group's and of the parent company's affairs as at 31 December 2021 and of the group's and the parent company's loss for the year then ended;

- have been properly prepared in accordance with IFRSs as adopted by the United Kingdom; and

- have been prepared in accordance with the requirements of the Companies Act 2006 and, as regards the group financial statements, Article 4 of the IAS regulation.

Β 

Separate opinion in relation to IFRSs as issued by the IASB

As explained in note 2 to the group financial statements, the group in addition to complying with its legal obligation to apply IFRSs as adopted by the United Kingdom, has also applied IFRSs as issued by the International Accounting Standards Board (IASB).

Β 

In our opinion the group financial statements give a true and fair view of the consolidated financial position of the group as at 31 December 2021 and of its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with IFRSs as issued by the IASB.

Β 

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard as applied to listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Β 

Material uncertainty related to going concern

We draw attention to note 2 in the financial statements, which indicates that there are events or conditions identified that may cast significant doubt on the entity's ability to continue as a going concern. The Company's listing with the London Stock Exchange is currently suspended, which creates uncertainty in respect of the timing of its re-listing. This unknown time frame has an effect on future trading and cash flows. In addition to this, the Company and Group have presented a loss for the year ended 31 December 2021, and, at the balance sheet date, both have net current liabilities. As stated in note 2, these events or conditions, along with the other matters as set forth in note 2, indicate that a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

Β 

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Our evaluation of the directors' assessment of the entity's ability to continue to adopt the going concern basis of accounting included

Β 

- Obtaining management's assessment of going concern of the Group and challenged the appropriateness of the assumptions used by utilising our knowledge of the Group gained throughout the audit and obtaining further corroborative audit evidence.

- Analysing forecasts prepared by management covering a period to 31 December 2023, which have been flexed using different variables for events over the corresponding period.

- Reviewing minutes of meetings of the Board for any factors that may affect going concern.

- Assessing the wider macro-economic environment over the period, in particular with respect of COVID-19 and Brexit.

- Considered publicly available information to identify if there is anything to contradict the assessment made by management, or if there are any indicators of potential risk to the group of industry.

- Assessing the appropriateness of going concern disclosure.

Β 

In relation to the entity's reporting on how they have applied the UK Corporate Governance Code, we have nothing material to add or draw attention to in relation to the directors' statement in the financial statements about whether the director's considered it appropriate to adopt the going concern basis of accounting.

Β 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Β 

Our approach to the audit

Β 

Tailoring of the audit scope

We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial statements as a whole, taking into account the structure of the group and the company, the accounting processes and controls, and the industry in which they operate

Β 

The group consists of the parent company and a subsidiary incorporated in the UK, for which a full scope audits were conducted, and an American based group (AAG), which consists of five companies and Ross Group Plc Inc. All subsidiaries were considered to be significant components, therefore audit work was completed on material balances. These group companies are listed in note 12 of the financial statements. There were no acquisitions during the reporting period, therefore the scope has not changed significantly compared to the prior period.

Β 

Procedures have been conducted on a group level to ensure the amounts brought into the consolidation are not materially misstated.

Β 

Materiality

The scope of our audit was influenced by our application of materiality. We set certain quantitative thresholds for materiality. These, together with qualitative considerations, helped us to determine the scope of our audit and the nature, timing and extent of our audit procedures on the individual financial statement line items and disclosures and in evaluating the effect of misstatements, both individually and in aggregate on the financial statements as a whole.

Β 

Β 

Key Audit Matter

How our scope addressed this matter

Revenue recognition

Revenue is recognised in accordance with the accounting policy set out in the notes to the consolidated financial statements (set out in note 2). The accounting policy contains a number of judgements with regards to revenue earned from contracts. This is considered to be a significant risk due to it often being contingent on external variables.

Β 

Performed substantive testing. We tested a sample of transactions from the point of origin, which were the original contracts, and traced these to the financial statements. Revenue of Ross Diversified Trading (RDT) tested substantively per the above. However, it was found that there was no further trading income to be recognised in the year, which is consistent with understanding of the business. Assessed whether income transactions were recorded in compliance with IFRS 15 and constitute an agent or principal relationship. Assessed the appropriateness of the related disclosures in the financial statements and consider them to be reasonable.

Β 

The key observations with regards to these risks were that we concurred that revenue had been recognised in accordance with IFRS 15 Revenue from contracts with customersand is materially appropriate or accurate.

Non-compliance with laws and regulations Ross Group Plc has a premium listing on the London Stock Exchange, and therefore needs to comply with a high level of regulation. Non- compliance with these laws and regulation could result in the parent company being de- listed from the London Stock Exchange, which would threaten the group and parent company's ability to continue. This is considered to be a significant risk.

Β 

Performed testing to ensure that the parent company is up to date with relevant fees due to regulators. Performed testing to ensure that all returns are submitted in accordance with requirements and within the specified timescales. Performed a detailed analysis of the relevant laws and regulations and discussed with management to outline the control processes to ensure compliance with these rules.

Β 

They key observation with regards to this risk was that the parent company is generally compliant with the requirements of the London Stock Exchange. It is noted that the Company is not currently compliant with the London Stock Exchange rules with regards to the filing of the financial statements, and the shares are currently suspended.

Β 

Β 

Key Audit Matter

How our scope addressed this matter

Going concern

The group is considered by the board to be a going concern, and the accounts have been prepared as appropriate on this basis, and therefore this judgement should be assessed. As the majority of the group companies do not trade or generate revenues, and the group is in a net liabilities position, there is a risk of material uncertainty relating to going concern, compounded with the current economic climate as a result of COVID-19.

Β 

In order to address this risk, a detailed review of going concern was conducted, which involved reviewing management's forecasts for the period up to December 2023, and challenging the assumptions made in preparation of this. Sensitivity analysis was conducted, and a 'worse' case scenario was assessed to consider the impact of this. Detailed discussions have been had with management on future plans, review of board meeting minutes, and review of the appropriateness of the going concern disclosure in note 2. The application of materiality is not as applicable in this area since this relates to the overall appropriateness of applying the going concern principle.

Β 

The key observations with regards to this risk are that due to the suspension of the shares with the London Stock Exchange, and the lack of financial support for the Company, there is a material uncertainty relating to going concern.

Accounting estimates

We will assess the impairments made by management to ensure that investments and fixed assets are not materially misstated in the financial statements.

Β 

We obtained an understanding of the impairment process and evaluated the impairment methodology and, tested the accuracy and completeness of the impairment review assessments. We gathered evidence from third parties, where possible, to corroborate cost assumptions included in calculations for future activity of operations for the forecasts. For those assets or investments impaired previously, we evaluated the actual results and the assumptions made and considered if reversals were required. We checked the recoverability of the receivables in AAG's accounts to gain direct written confirmations on the existence of these assets from third parties. And obtained evidence from third parties of financial stability and ability to repay to test recoverability. We enquired management regarding the intention of the group balances, and whether these should be netted off.

Β 

Our application of materiality

Based on our professional judgement, we determined materiality for the financial statements as a whole as follows: group and parent company materiality for the financial statements as a whole at

Β£29,100 and Β£26,300 respectively, which is based on 2% of loss before tax after the removal of exceptional items at the planning stage. Materiality has been set using this measure as this is considered to represent the most appropriate measure of underlying performance, which is the most sensitive measure being a listed group. The group and parent company performance materiality adopted is 50% of this figure, which was calculated as Β£14,500 and Β£13,100 respectively. This is deemed by the audit team to be an appropriate level to identify material errors, which is used for a high-risk audit. The materiality at completion has been assessed and it was noted that the loss before tax had increased as a result of an audit adjustment, however it was concluded that materiality should not be amended. Materiality has influenced our workings not only for the key audit matters but also for the rest of the work performed during the audit. Anything below Β£1,450 and Β£1,300 was considered trivial from a group and parent company perspective respectively.

Β 

We agreed with the audit committee that we would report to them misstatements identified during our audit above Β£1,450 or Β£1,300 as appropriate as well as misstatements below that amount that, in our view, warranted reporting for qualitative reasons.

Β 

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

Β 

We have nothing to report in this regard.

Β 

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, the part of the directors' remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006. In our opinion, based on the work undertaken in the course of the audit:

- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements and those reports have been prepared in accordance with applicable legal requirements;

- the information about internal control and risk management systems in relation to financial reporting processes and about share capital structures, given in compliance with rules 7.2.5 and 7.2.6 in the Disclosure Rules and Transparency Rules sourcebook made by the Financial Conduct Authority (the FCA Rules), is consistent with the financial statements and has been prepared in accordance with applicable legal requirements; and

- information about the company's corporate governance code and practices and about its administrative, management and supervisory bodies and their committees complies with rules 7.2.2, 7.2.3 and 7.2.7 of the FCA Rules.

Β 

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in;

- the strategic report or the directors' report; or

- the information about internal control and risk management systems in relation to financial reporting processes and about share capital structures, given in compliance with rules 7.2.5 and 7.2.6 of the FCA Rules.

Β 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

- the parent company financial statements and the part of the directors' remuneration report to be audited are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit; or

- a corporate governance statement has not been prepared by the parent company.

Β 

Corporate governance statement

The Listing Rules require us to review the directors' statement in relation to going concern, longer- term viability and that part of the Corporate Governance Statement relating to the group's compliance with the provisions of the UK Corporate Governance Statement specified for our review.

Β 

Based on the work undertaken as part of our audit, we have concluded that each of the following elements of the Corporate Governance Statement is materially consistent with the financial statements or our knowledge obtained during the audit:

- Directors' statement with regards the appropriateness of adopting the going concern basis of accounting and any material uncertainties identified (set out on page 10);

- Directors' explanation as to its assessment of the entity's prospects, the period this assessment covers and why they period is appropriate (set out on page 13).

- Directors' statement is fair, balanced and understandable (set out on page 14);

- Board's confirmation that it has carried out a robust assessment of the e-merging and principal risks (set out on page 14);

- The section of the annual report that describes the review of effectiveness of risk management and internal control systems (set out on page 13); and;

- The section describing the work of the audit committee (set out on page 14).

Β 

Responsibilities of directors

As explained more fully in the directors' responsibilities statement set out on page 11, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Β 

Auditor's Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Β 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Β 

We ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations. The laws and regulations applicable to the company were identified through discussions with directors and other management, and from our commercial knowledge and experience of a premium listed group undertaking various global activities. Of these laws and regulations, we focused on those that we considered may have a direct material effect on the financial statements or the operations of the company, including the Listing Rules of the Financial Conduct Authority (FCA), Companies Act 2006, taxation legislation, data protection, anti-bribery, anti-money-laundering, employment, environmental and health and safety legislation. The extent of compliance with these laws and regulations identified above was assessed through making enquiries of management and inspecting legal correspondence. The identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

Β 

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud;

- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations; and

- understanding the design of the company's remuneration policies.

Β 

To address the risk of fraud through management bias and override of controls, we:

- performed analytical procedures to identify any unusual or unexpected relationships;

- tested journal entries to identify unusual transactions;

- assessed whether judgements and assumptions made in determining the accounting estimates set out in note 2 were indicative of potential bias; and

- investigated the rationale behind significant or unusual transactions.

Β 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

- agreeing financial statement disclosures to underlying supporting documentation;

- reading the minutes of meetings of those charged with governance;

- enquiring of management as to actual and potential litigation and claims; and

- reviewing correspondence with HMRC, relevant regulators including the FCA and the company's legal advisors.

Β 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non- compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

Β 

A further description of our responsibilities is available on the Financial Reporting Council's website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Β 

Other matters which we are required to address

Following the recommendation of the audit committee, we were appointed by the board of directors on 20 May 2021 to audit the financial statements for the year ending 31 December 2021 and subsequent financial periods. The period of total uninterrupted engagement is 3 years, covering the years ending 31 December 2019 to 31 December 2021.

Β 

The non-audit services prohibited by the FRC's Ethical Standard were not provided to the group or the parent company and we remain independent of the group and the parent company in conducting our audit.

Β 

Our audit opinion is consistent with the additional report to the audit committee.

Β 

Use of our report

This report is made solely to the parent company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Β 

Β 

Β 

Β 

Β 

Β 

Daniel Howarth FCA (Senior Statutory Auditor) for and on behalf of CBW Audit Limited Chartered Accountants

Statutory Auditors 66 Prescot Street London

E1 8NN

Β 

Date:

Β 

Β 

Β 

Β 

Β 

Revenue

Β 

Notes

2021

Β£'000

Β 

Β 

-

2020

Β£'000

Restated

Β 

43

Production expenses

Β 

Gross profit / (loss)

-

────

-

(39)

────

4

Other operating income

5

5

135

Administrative expenses

Β 

Operating (loss)

(1,878)

──── (1,873)

(894)

──── (755)

Finance income

8

1

1

Finance expense

Β 

(Loss) before income tax

8

Β 

7

(704)

──── (2,576)

(491)

──── (1,245)

Income tax

Β 

(Loss) for the year

9

-

──── (2,576)

════

-

──── (1,245)

════

Β 

(Loss) attributable to: Owners of the parent

Β 

Β 

(2,576)

Β 

Β 

(1,245)

════

════

Β 

Earnings per share expressed in pence per share: Basic

Β 

10

Β 

Β 

(1.11)

Β 

Β 

(0.57)

Diluted

(0.85)

════

(0.44)

════

Β 

Earnings per share from continuing operations Basic

Β 

Β 

(1.11)

Β 

Β 

(0.57)

Diluted

(0.85)

════

(0.44)

════

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

The notes form part of these financial statements.

Β 

Β 

Β 

Β 

Continuing operations

Β 

Notes

2021

Β£'000

2020

Β£'000

Restated

Revenue

-

-

Other operating income

5

22

30

Administrative expenses

Β 

Operating (loss)

(2,782)

──── (2,760)

(220)

──── (190)

Finance costs

Β 

(Loss) before income tax

8

Β 

7

(612)

──── (3,372)

(366)

──── (556)

Income tax

Β 

(Loss) for the year

9

-

──── (3,372)

════

-

──── (556)

════

Β 

Β 

2021

Β£'000

2020

Β£'000

Restated

(Loss) for the year

(2,576)

(1,245)

Exchange losses arising on translation of foreign operations

(13)

(89)

Β 

Total comprehensive income for the year

──── (2,589)

════

──── (1,334)

════

Β 

Total comprehensive income attributable to: Owners of the parent

Β 

Β 

(2,589)

Β 

Β 

(1,334)

════

════

Β 

Β 

2021

Β£'000

2020

Β£'000

Restated

(Loss) for the year

(3,372)

(556)

Exchange losses arising on translation of foreign operations

-

-

Β 

Total comprehensive income for the year

──── (3,372)

════

──── (556)

════

Β 

Β 

Β 

Assets

Β 

Notes

2021

Β£'000

2020

Β£'000

Restated

Current assets

Trade and other receivables

Β 

16

Β 

117

Β 

310

Cash and cash equivalents

Β 

Β 

Non-Current assets

17

209

─────

326

─────

91

─────

401

─────

Investments

12

-

424

Property, plant and equipment

13

27

313

Right-of-use assets

14

41

311

Intangible assets

Β 

Total assets Equity

15

-

─────

68

─────

394

═════

-

───── 1,048

───── 1,449

═════

Shareholders' equity

Called up share capital

Β 

18

Β 

11,232

Β 

11,218

Share premium

19

3,540

3,146

Other reserves

19

15,384

15,384

Convertible debenture

19

4,692

5,145

Translation reserve

19

(212)

(199)

Retained earnings

Total equity Liabilities

19

(41,943)

───── (7,307)

─────

(39,820)

───── (5,126)

─────

Non-current liabilities

Lease liabilities

Β 

14

Β 

10

Β 

183

Financial liabilities

21

3,003

2,551

Provisions

Β 

Β 

Current liabilities

26

813

───── 3,826

─────

-

───── 2,734

─────

Trade and other payables

20

3,315

3,408

Lease liabilities

14

37

208

Financial liabilities

Β 

Β 

Total liabilities

21

523

───── 3,875

───── 7,701

─────

225

───── 3,841

───── 6,575

─────

Total equity and liabilities

394

═════

1,449

═════

The financial statements were approved by the Board of Directors on 2022 and were signed on its behalf by:

Β 

Β 

………………………………………. ……………………………………….

B Pettitt - Director M J L d'Hombres - Director

Β 

Β 

Β 

Assets

Β 

Notes

2021

Β£'000

2020

Β£'000

Restated

Current assets

Trade and other receivables

Β 

16

Β 

78

Β 

763

Cash and cash equivalents

Β 

Β 

Non-Current assets

17

193

─────

271

─────

44

─────

807

─────

Investments

12

-

627

Property, plant and equipment

13

16

─────

16

─────

20

─────

647

─────

Total assets

287

─────

1,454

─────

Equity

Shareholders' equity

Called up share capital

Β 

Β 

18

Β 

Β 

11,232

Β 

Β 

11,218

Share premium

19

3,540

3,146

Other reserves

19

30,938

30,938

Convertible debenture

19

4,692

5,145

Retained earnings

Β 

Total equity

19

(55,239)

─────

(4,837)

─────

(52,320)

───── (1,873)

─────

Liabilities

Non-current liabilities

Financial liabilities

Β 

Β 

21

Β 

Β 

3,003

Β 

Β 

2,551

Provisions

26

813

───── 3,816

─────

-

───── 2,551

─────

Current liabilities

Trade and other payables

Β 

20

Β 

914

Β 

551

Financial liabilities

21

394

───── 1,308

─────

225

─────

776

─────

Total liabilities

5,124

─────

3,327

─────

Total equity and liabilities

287

═════

1,454

═════

Β 

The financial statements were approved by the Board of Directors on 2022 and were signed on its behalf by:

Β 

Β 

……………………………… ………………………………

B Pettitt - Director M J L d'Hombres - Director

Β 

Β 

Called up

Share capital

Retained

earnings

Share

premium

Β£'000

Β£'000

Restated

Β£000

Balance at 1 January 2020

11,218

(38,784)

3,146

Changes in equity

Issue of share capital

Β 

-

Β 

-

Β 

-

Total comprehensive income

-

(1,245)

-

Derecognition of conversion rights on loans

-

-

-

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2020

-

───── 11,218

─────

209

───── (39,820)

─────

-

───── 3,146

─────

Changes in equity

Issue of share capital

Β 

14

Β 

-

Β 

394

Total comprehensive income

-

(2,576)

-

Derecognition of conversion rights on loans

-

-

-

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2021

-

─────

11,232

─────

453

─────

(41,943)

─────

-

─────

3,540

─────

Β 

Translation

Β 

Other

Β 

Convertible

Β 

Total

reserves

reserves

debenture

equity

Β£'000

Restated

Β£'000

Β£'000

Restated

Β£'000

Restated

Balance at 1 January 2020 (110)

15,384

5,354

(3,792)

Changes in equity

Issue of share capital -

Β 

-

Β 

-

Β 

-

Total comprehensive income (89)

-

-

(1,334)

Derecognition of conversion rights

on loans -

Β 

-

Β 

(5,354)

Β 

(5,354)

Value of conversion rights on

convertible loans -

Β 

-

Β 

5,145

Β 

5,354

─────

─────

─────

─────

Balance at 31 December 2020 (199)

15,384

5,145

(5,126)

─────

─────

─────

─────

Changes in equity

Issue of share capital -

Β 

-

Β 

-

Β 

408

Total comprehensive income (13)

-

-

(2,589)

Derecognition of conversion rights

on loans -

Β 

-

Β 

(5,145)

Β 

(5,145)

Value of conversion rights on

convertible loans -

Β 

-

Β 

4,692

Β 

5,145

─────

─────

─────

─────

Balance at 31 December 2021 (212)

15,384

4,692

(7,307)

═════

═════

═════

═════

Β 

Β 

Called up

Share capital

Retained

earnings

Share

premium

Β£'000

Β£'000

Restated

Β£000

Balance at 1 January 2020

11,218

(51,973)

3,146

Changes in equity

Issue of share capital

Β 

-

Β 

-

Β 

-

Total comprehensive income

-

(556)

-

Derecognition of conversion rights on loans

-

-

-

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2020

-

───── 11,218

─────

209

───── (52,320)

─────

-

───── 3,146

─────

Changes in equity

Issue of share capital

Β 

14

Β 

-

Β 

394

Total comprehensive income

-

(3,372)

-

Derecognition of conversion rights on loans

-

-

-

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2021

-

─────

11,232

─────

453

─────

(55,239)

─────

-

─────

3,540

─────

Β 

Other reserves

Β£'000

Β 

Convertible debenture

Β£'000

Restated

Β 

Total equity

Β£'000

Restated

Balance at 1 January 2020

30,938

5,354

(1,317)

Changes in equity

Issue of share capital

Β 

-

Β 

-

Β 

-

Total comprehensive income

-

-

(556)

Derecognition of conversion rights on loans

-

(5,354)

(5,354)

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2020

-

───── 30,938

─────

5,145

───── 5,145

─────

5,354

───── (1,873)

─────

Changes in equity

Issue of share capital

Β 

-

Β 

-

Β 

408

Total comprehensive income

-

-

(3,372)

Derecognition of conversion rights on loans

-

(5,145)

(5,145)

Value of conversion rights on convertible loans

Β 

Balance at 31 December 2021

-

───── 30,938

═════

4,692

───── 4,692

═════

5,145

───── (4,837)

═════

Β 

Β 

Notes

Β 

Cash flows from operating activities

2021

Β£'000

2020

Β£'000

Restated

(Loss) before income tax

(2,576)

(1,125)

Investment impairment provision

486

-

Depreciation of property, plant and equipment

6

4

Loss of sale of property, plant and equipment

2,711

121

Reverse impairment of property, plant and equipment

(3,048)

(167)

Impairment of property, plant and equipment

-

207

Amortisation of right-of-use assets

33

202

Impairment of intangible assets

-

-

Foreign exchange adjustments

(4)

9

Finance expense

704

282

Finance income

(1)

──── (1,689)

(1)

──── (468)

Decrease / (Increase) in trade and other receivables

212

(187)

Decrease in inventories

-

39

(Decrease) / increase in trade and other payables Net cash from operating activities

592

────

(885)

────

453

──── (163)

────

Cash flows from investing activities

Purchase of fixed asset investments

Β 

(62)

Β 

(424)

Purchase of property, plant and equipment

(13)

(65)

Proceeds from sale of property, plant and equipment

867

470

Interest received on loans

Β 

Net cash from investing activities

1

────

793

────

1

────

(18)

────

Cash flows from financing activities

Issue of ordinary shares

Β 

408

Β 

-

Proceeds from new loans issued

401

162

Repayment of loans and borrowings

(3)

-

Interest paid on loans and borrowings

(247)

(250)

Principal paid on lease liabilities

(345)

(219)

Interest paid on lease liabilities

(4)

(32)

Amount withdrawn by directors Net cash from financing activities

-

────

210

────

(38)

──── (377)

────

(Decrease) / increase in cash and cash equivalents

118

(558)

Cash and cash equivalents at beginning of year 1

Cash and cash equivalents at end of year 1

91

────

209

════

649

────

91

════

Β 

Β 

Β 

Notes

2021

Β£'000

2020

Β£'000

Restated

Cash flows from operating activities

(Loss) before income tax

Β 

(3,372)

Β 

(347)

Impairment provision

689

-

Foreign exchange adjustment

11

-

Finance cost

612

157

Depreciation

4

──── (2,056)

-

──── (190)

Decrease / (Increase) in trade and other receivables

703

(236)

Increase in trade and other payables Net cash from operating activities

1,157

──── (196)

────

331

────

(95)

────

Β 

Cash flows from investing activities

Purchase of fixed asset investments

Β 

Β 

(62)

Β 

Β 

(424)

Purchase of property, plant and equipment Net cash from investing activities

-

────

(62)

────

(20)

──── (444)

────

Β 

Cash flows from financing activities

Issue of ordinary shares

Β 

Β 

408

Β 

Β 

-

Proceeds from new loans issued

160

138

Repayment of loans and borrowings

(3)

-

Interest paid on loans and borrowings

(159)

(158)

Amount withdrawn by directors

-

(33)

Amount introduced by directors Net cash from financing activities

1

────

407

────

-

────

(53)

────

Increase / (decrease) in cash and cash equivalents

149

(592)

Cash and cash equivalents at beginning of year 1

Cash and cash equivalents at end of year 1

44

────

193

════

636

────

44

════

Β 

Β 

1. Cash and cash equivalents

Β 

The amounts disclosed on the Cash Flow Statements in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Β 

Β 

Year ended 31 December 2021

Group

Company

31/12/21 01/01/21

Β£'000 Β£'000

31/12/21 01/01/21

Β£'000 Β£'000

Cash and cash equivalents

209 91

════ ════

193 44

════ ════

Β 

Year ended 31 December 2020

Β 

Β 

31/12/20 01/01/20

Β 

Β 

31/12/20 01/01/20

Β£'000 Β£'000

Β£'000 Β£'000

Cash and cash equivalents

91 649

════ ════

44 636

════ ════

For the year ended 31 December 2021

Β 

Β 

Β 

1. Statutory Information

Β 

Ross Group Plc is a public company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the General Information page. The subsidiary, Ross Diversified Trading Limited, is a private company limited by shares and registered in England and Wales. The subsidiary, Ross Group Plc Inc, is a close corporation, limited by shares and registered in USA. The subsidiary, Archipelago Aquaculture Group LLC, is a limited liability company registered in USA.

Β 

The following companies are all subsidiaries of Archipelago Aquaculture Group LLC.

Β 

The subsidiary, Mari Signum Limited, is a company limited by shares and registered in USA. The subsidiary Mari Signum Mid-Atlantic LLC, is a limited liability company registered in USA. The subsidiary Mari Signum Dragon Drying - MS LLC, is a limited liability company registered in USA. The subsidiary Prometheus Progeniture Genetics Technologies Limited LLC, is a limited liability company registered in USA.

Β 

2. Accounting Policies Basis of preparation

The consolidated financial statements of Ross Group Plc have been prepared in accordance with International Financial Reporting Statements (IFRS) and interpretations issued by the IFRS Interpretations Committee (IFRS IC) as adopted by the UK and the Republic of Ireland and with the Companies Act 2006 as applicable to companies reporting under IFRS. The financial statements have been prepared on a historical cost basis and on a going concern basis.

Β 

Items included in the financial statements of each of the group's entities are measured using the currency of the primary economic environment in which the entity operates ('the functional currency'). The consolidated financial statements are presented in British Pounds (GBP), which is Ross Group Plc's functional and presentation currency. Amounts are rounded to the nearest thousand.

Β 

In preparing the financial statements for the current period, the group has adopted the following new IFRS's, amendments to IFRS's and IFRS Interpretations Committee (IFRIC) Interpretations. These standards do not have a significant impact on the results or net assets of the group.

Β 

IFRS 7 (amended) Financial Instruments: Disclosures IFRS 9 (amended) Financial Instruments

IFRS 16 (amended) Leases

Β 

Β 

New standards, amendments and interpretations that are not effective for the year ended 31 December 2021

Β 

On the date of approval of these financial statements, the following accounting standards have been issued by the International Accounting Standards Board but were not yet effective:

Β 

Β 

2. Accounting policies - continued

Β 

New standards and amendments which are not effective for the current year and have been endorsed by the UK and the Republic of Ireland.

Β· Amendments to IAS 1 Presentation of Financial Statements (Effective for annual reporting periods beginning on or after 1 January 2023)

Β· Amendment to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors (Effective for annual reporting periods beginning on or after 1 January 2023)

Β· Amendment to IAS 12 Income Taxes (Effective for annual reporting periods beginning on or after 1 January 2023)

Β· Amendment to IAS 16 Property, Plant and Equipment (Effective for annual reporting period beginning on or after 1 January 2022)

Β· Amendment to IAS 37 Provisions, Contingent Liabilities and Contingent Assets (Effective for annual reporting periods beginning on or after 1 January 2022)

Β· Amendment to IFRS 3 Business Combinations (Effective for annual reporting period beginning on or after 1 January 2022)

Β· IFRS 17 Insurance Contracts (Effective for annual reporting periods beginning on or after 1 January 2023)

Β 

The Group is in the process of assessing the impact of new and revised standards but does not expect that the application of the new standards will have a significant impact on the Group's financial statements.

Β 

Going concern

The Group's business activities, together with the factors likely to affect the future performance and position are set out in the Strategic Report on pages 6 to 11.

Β 

As described in the Business Review on pages 6 to 7 the Group has restructured its Chitin operations in favour of entering into an agreement with 525 Solutions who have undertaken a controlling shareholding in RGP 525 - with the Group holding a balance 19.9% shareholding in RGP525 - in order to continue to explore opportunities to mass produce Chitin in a way never before undertaken and, given this, there is undoubtably an uncertainty as to how long it will take to achieve these aims and generate income. Although this uncertainty exists, the Group are working with such experts in this field who are also integrally involved in this process and are therefore confident in the possibility of its long term success. The Directors have instituted measures to preserve cash by also restructuring the Group's finances and through the RGP525 venture have ensured the limiting of any further cost exposure, although if the proof of mass production is proven to be successful, the Group will look to secure additional finance, if so required. In this respect, our strategic approach and implementation has ceased to create any cash flow issues flows from this particular sector of the Group's business.

Β 

The Directors have now decided to re-focus their efforts on pursuing other opportunities during these exceptional post COVID times and have commenced trading within the wholly owned subsidiary company, Ross Diversified Trading Limited, regarding supply chain management contracts in the commodities sector. A number of other such opportunities are also currently being explored in other sectors and it is anticipated that a number of transactions in these areas will conclude during the 2022 and/or 2023 financial years with a view to increasing both revenue and profitability in the group.

Β 

The Board is reasonably confident, notwithstanding the COVID Pandemic and its subsequent ongoing economic effects, that there will still be various unique and exciting opportunities ahead- both in the short term and longer term - in order for its overall business to be sustained and for potential growth to be considered in the future.

Β 

.

Β 

Β 

2. Accounting policies - continued

Β 

The Group continues to negotiate the sale of certain assets and the settlement of the current and contingent liabilities, following the restructure of the AAG group and would hope to bring these to conclusion in the next twelve to eighteen months. The Board have prepared cash flow forecasts to December 2023 - including sensitivity testing on these forecasts - and are reasonably satisfied that once the temporary suspension of the shares is released on filing of the financial statements the Group has sufficient cash available to it from various sources and letters of interest to invest in new share offerings in order to meet its liabilities as they fall due for a period of at least twelve months from the signing of the financial statements.

Β 

Based on the above, the Board believe that it remains appropriate to prepare the financial statements on a going concern basis. However, these circumstances represent a material uncertainty that may cast doubt on the Company's and Group's ability to continue as a going concern and therefore to continue realising its assets and discharging its liabilities in the normal course of business. The financial statements do not include any adjustments that would result from this basis of preparation being inappropriate.

Β 

Basis of consolidation

The group financial statements consolidate those of the company and of its subsidiary undertakings drawn up to 31 December 2021. Profits or losses on intra-group transactions and intra-group balances are eliminated in full. On acquisition of a subsidiary, all of the subsidiary's assets and liabilities which exist at the date of acquisition are recorded at their fair values reflecting their condition at that date.

Β 

The AAG group has not generated any revenue, the decision has been made to restructure this group of companies, post new venture in 2020 and continued in 2021.

Β 

Revenue recognition

Revenue is the total amount receivable by the group for goods supplied and services provided to third parties, excluding VAT.

Β 

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually when the goods have been delivered to customers such that the risks and removal of ownership have been transferred to them.

Β 

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion, when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable. A level of judgement is exercised by management in this regard.

Β 

Goodwill

Goodwill represents the excess of the cost of a business combination over the group's interest in the fair value of identifiable assets, liabilities and contingent liabilities acquired.

Β 

Goodwill is capitalised as an intangible asset with any impairment in carrying value being charged to the consolidated statement of comprehensive income. Where the fair value of identifiable assets, liabilities and contingent liabilities exceed the fair value of consideration paid, the excess is credited in full to the consolidated statement of comprehensive income on the acquisition date.

Β 

2. Accounting policies - continued Property, plant and equipment

Property plant and equipment are carried at cost or deemed cost (fair value on acquisition through business combination) less accumulated depreciation and impairment provisions.

Β 

Acquisition cost includes the purchase price plus other costs related to acquisition, such as freight, postage, duties, commissions, interest on investment loans recorded before the tangible assets are capitalised or before they are put into use.

Β 

The costs of expansion, modernisation, or improvements leading to increased productivity, capacity or efficiency are capitalised. Maintenance and repair expenses are expensed as incurred.

Β 

Where the carrying amount of an asset is greater than the amount that it is estimated to be recoverable, it is written down to its recoverable amount.

Β 

The Group depreciates its property, plant and equipment on a straight line basis in order to write off the cost of each asset less the estimated residual value over its estimated useful life as follows:

Β 

Building 39 years straight line basis

Leasehold improvements Over the term of the lease Plant, machinery and equipment 7 years straight line basis Right of use assets Over the term of the lease

Β 

Financial instruments

Financial assets and liabilities are recognised on the statement of financial position when the entity becomes party to the contractual provisions of the instrument.

Β 

The Group's financial instruments consist primarily of cash and cash equivalents, accounts receivable and accounts payable.

Β 

Financial liabilities

The group recognises financial debt when the group becomes a party to the contractual provisions of the instruments.

Β 

Financial liabilities, including borrowings, trade payables and other short-term monetary liabilities, are initially measured at fair value net of transactions costs directly attributable to the issuance of the financial liability. They are subsequently measured at amortised cost using the effective interest method. For the purposes of each financial liability, interest expense includes initial transaction costs and any premium payable on redemption, as well as any interest or coupon payable while the liability is outstanding.

Β 

Derecognition of financial liabilities

Financial liabilities are derecognised when, and only when, the group's obligations are discharged, cancelled, or they expire.

Β 

Cash and cash equivalents

For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand and deposits held at call with financial institutions.

Β 

Trade receivables

Trade receivables are recognised initially at fair value and subsequently measured at amortised cost using the effective method, less loss allowance.

Β 

2. Accounting policies - continued

Β 

Prepayments from clients

Payments received in advance on sale contracts for which no revenue has been recognised yet are recorded as prepayments from clients as the reporting date and carried under liabilities.

Β 

Investments and other financial assets

The group classifies its debt instruments in the category those to be measured at amortised cost, which are assets held for collection of contractual cash flows, where those cash flows represent solely payments of principal and interest. Financial assets are derecognised when the rights to receive cash flows from the financial assets have expired or have been transferred and the group has transferred substantially all the risks and rewards of ownership.

Β 

Any gain or loss arising on derecognition is recognised directly in profit or loss and presented in other gains/(losses) together with foreign exchange gains and losses. Impairment losses are presented as a separate line item in the income statement. The group subsequently measures all equity investments at cost.

Β 

The group assesses, on a forward-looking basis, the expected credit losses associated with its debt instruments carried at amortised cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk.

Trade and other payables

These amounts represent liabilities for goods and services provided to the group prior to the end of the financial year which are unpaid. The amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are recognised initially at their fair value and subsequently measured at amortised cost using the effective interest method.

Deferred taxation

A deferred tax asset is provided for if material, using the tax rates estimated to arise when the timing differences reverse and is accounted for to the extent that it is probable that an asset will crystallise.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Foreign currencies

Transactions denominated in foreign currencies are translated at the exchange rate ruling at the date of the transaction. Monetary assets and liabilities in foreign currencies are translated at the rates of exchange ruling at the year end date. These transaction differences are dealt with in the income statement. The financial statements of foreign subsidiaries are translated at the rate of exchange ruling at the year end date. The exchange differences arising from the retranslation of the opening net investment in subsidiaries are taken directly to reserves.

Β 

Β 

3. Critical accounting estimates and judgements

The Group makes certain estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.

Estimates and assumptions

-Β  The determination of lease term for some lease contracts in which the Group is a lessee, including whether the Group is reasonably certain to exercise lessee options (see note 16)

-Β  The determination of the incremental borrowing rate used to measure the lease liabilities (see note 14)

Β 

- Depreciation of property, plant and equipment - Estimate of the useful economic life (see note 13)

-Β  The determination of the discount rate used to measure the convertible loan debenture (see note 21)

-Β  Impairment of property, plant and equipment - Estimate of the net realisable value of property, plant and equipment held at the year end (see note 13).

Β 

-Β  Provision for legal expenses - Estimate of the expenses payable (see note 26).

Β 

-Β  Impairment of investments - Estimate of the profitability of the companies (see note 12).

Β 

-Β  Related party debtors - Estimate of the recoverability of the debts (see note 16).

Β 

4. Segmental reporting

The directors feel that due to no revenue earned this year and little trading during the previous year it is not possible to identify any segments and as a result cannot follow IFRS 8. The entire turnover in the previous year was generated within the UK but delivered overseas through the rendering of services related to the principal activity of the Group.

Β 

The loss for the year was incurred mainly by the parent company itself, Ross Group Plc, based in the United Kingdom arising from administration costs incurred in pursuit of new opportunities. Whilst Ross Diversified Trading Limited had a small amount of trade in 2020 this has reduced in 2021 but is anticipated to increase again.

The main contributor to the loss incurred during the previous year was the subsidiary group AAG LLC based in the USA. This group was acquired in January 2019 and due to unforeseen circumstances ceased to operate throughout 2020 being included in the prior year financial statements as a discontinued operation. Expenses are still being incurred for this group as operations are wound up and/or transferred to its venture RGP-525.

The directors will review this assessment next year.

Β 

Β 

5. Other operating income

Group

2021

Β£'000

2020

Β£'000

Restated

Government grants receivable

1

135

Compensation receivable

4

────

5

════

-

────

135

════

Company

2021

Β£'000

2020

Β£'000

Restated

Other miscellaneous income

22

════

30

════

6. Employees and directors

Employee benefit expenses (including directors) comprise:

Β 

2021

Β 

2020

Β£

Β£

Wages and salaries

-

129,923

Directors' remuneration

5

5

Social security contributions and similar taxes

-

─────

5

═════

4,957

───── 134,885

═════

The average number of employees during the year was as follows:

Β 

2021

Β 

2020

Number

Number

Management

8

8

Production

-

-

Administrative

-

────

8

════

3

────

11

════

Ross Group Plc & Subsidiaries

Notes to the Consolidated Financial Statements For the year ended 31 December 2021

Β 

Β 

Β 

7. Loss before income tax

The loss before income tax is stated after charging:

Β 

2021

Β 

2020

Β£'000

Β£'000

Restated

Auditor's remuneration

110

74

Impairment of investment

486

-

Amortisation of right-of-use assets

33

202

Depreciation of property, plant and equipment

6

4

Impairment of property, plant and equipment

-

207

Reverse of impairment of property, plant and equipment

(3,048)

(167)

Loss on disposal of property, plant and equipment

2,471

151

Loss on disposal of right-of-use assets

240

-

Associated undertaking loan write back

(30)

════

(25)

════

8. Finance income and expense

Group

Β 

2021

Β 

2020

Β 

Β 

Finance income

Β£'000

Β£'000

Restated

Interest income on financial assets

1

════

1

════

Β 

Β 

Β 

Finance expense

2021

Β£'000

2020

Β£'000

Restated

Interest expense on financial liabilities

166

185

Interest expense on lease liabilities

4

32

Interest expense on convertible debenture

81

65

Reserves adjustment of convertible debenture

453

────

704

════

209

────

491

════

Company

Β 

2021

Β 

2020

Β 

Β 

Finance expense

Β£'000

Β£'000

Restated

Interest expense on financial liabilities

78

92

Interest expense on convertible debenture

81

65

Reserves adjustment of convertible debenture

453

────

612

════

209

────

366

════

Β 

Β 

9. Income tax

Β 

No liability for UK corporation tax arose on ordinary activities for the year ended 31 December 2021 or for the year ended 31 December 2020. The Group made a loss during the year.

Β 

Subject to the agreement with HM Revenue and Customs, the Group has allowable trading losses at 31 December 2021 for set-off against future trading profits of Β£13.78m (2020: Β£13.25m).

Β 

A deferred tax asset of Β£3.45m (2020: Β£2.46m) arises due to the large losses described above. As the timing of when the Group will be able to make use of these losses the asset has not been recognised in the financial statements.

Β 

Β 

10. Earnings per share

Β 

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

Β 

Diluted earnings per share is calculated using the weighted average number of shares adjusted to assume the conversion of all dilutive potential ordinary shares.

Β 

Reconciliations are set out below.

2021

Weighted average number

Β 

Β 

Pre-share

Earnings

Β£'000

of shares

amount pence

Basic EPS

Earnings attributable to ordinary shareholders

Β 

(2,576)

Β 

233,000,000

Β 

(1.11)

Effect of dilutive securities

Β 

Diluted EPS

-

─────

68,851,000

────────

-

─────

Adjusted earnings

(2,576)

═════

301,851,000

════════

(0.85)

═════

Β 

2020

Weighted

average number

Β 

Β 

Β 

Pre-share

Β 

Β 

Basic EPS

Earnings

Β£'000

Restated

of shares

amount pence

Earnings attributable to ordinary shareholders

(1,245)

218,767,475

(0.57)

Effect of dilutive securities

Β 

Diluted EPS

-

─────

64,645,789

────────

-

─────

Adjusted earnings

(1,245)

═════

283,413,264

════════

(0.44)

═════

Β 

Β 

11. Subsidiaries

Β 

At 31 December 2021 the company held 100% of the allotted equity share capital of the following:-

Β 

Country of

Name of subsidiary

registration and Class of share

undertaking

incorporation capital held

Nature of business

Β 

Ross Diversified Trading Limited England and Wales Ordinary Supply chain management (formerly Sansui Electronics (UK)

Limited)

Β 

Β 

The costs of this fixed asset investment have been written off over the previous periods.

Β 

Β 

Archipelago Aquaculture Group LLC Mari Signum Limited

Mari Signum Dragon Drying-MS LLC

Β 

Mari Signum Mid-Atlantic II LLC

USA USA USA

USA

Ordinary Ordinary Ordinary

Ordinary

Intermediate holding company Aquaculture support

Drying Shrimp hulls

Β 

Aquaculture support

Prometheus Progeniture Genetics Technologies Limited LLC

Β 

USA

Β 

Ordinary

Β 

Genetic enhancement of

colossal shrimp for higher quality chitin.

Ross Group Plc Inc

USA

Ordinary

Supply chain management

Β 

Β 

12. Investments

Β 

Unlisted

Group investments

Β£'000

Cost

At 1 January 2021 424

Additions 62

Disposals -

────

At 31 December 2021 486

────

Provisions

At 1 January 2021 -

Impairments 486

Disposals -

────

At 31 December 2021 486

════

Net book value

At 31 December 2021 -

════

At 31 December 2020 424

════

Unlisted

Company investments

Β£'000

Cost

At 1 January 2021 643

Additions 62

Disposals -

────

At 31 December 2021 705

────

Provisions

At 1 January 2021 16

Impairments 689

Disposals -

────

At 31 December 2021 705

════

Net book value

Β 

At 31 December 2021 -

════

At 31 December 2020 627

════

13. Property, plant and equipment

Group

Land and

buildings

Plant and

machinery

Β 

Totals

Β£'000

Β£'000

Β£'000

Cost

At 1 January 2021

293

20

313

Additions

-

13

13

Disposals

(293)

(3,048)

(3,341)

Impairment reversal

-

3,048

3,048

────

─────

─────

At 31 December 2021

-

33

33

════

═════

═════

Depreciation

At 1 January 2021

-

-

-

Charge for the year

-

6

6

Disposals

-

-

-

Impairment

-

-

-

────

─────

─────

At 31 December 2021

-

6

6

════

═════

═════

Net book value

At 31 December 2021

-

27

27

═════

═════

═════

At 31 December 2020

293

20

313

═════

═════

═════

In December 2019 the group ceased trading in its US subsidiaries, Archipelago Aquaculture Group LLC, at the time the plant and machinery operated by the group were impaired to nil as the assets were no longer in use. During 2021 some of the equipment was sold to third parties resulting in the impairment been reversed.

Β 

Β 

Company

Plant and

machinery

Β 

Totals

Β£'000

Β£'000

Cost

At 1 January 2021

20

20

Additions

-

-

Disposals

-

-

─────

─────

At 31 December 2021

20

20

═════

═════

Depreciation

At 1 January 2021

-

-

Charge for the year

4

4

Disposals

-

-

─────

─────

At 31 December 2021

4

4

═════

═════

Net book value

At 31 December 2021

16

16

═════

═════

At 31 December 2020

20

20

═════

═════

Β 

Β 

14. Leases

Right-of-use Assets

Β 

Land and

buildings

Β£'000

Total

Β£'000

At 1 January 2021

311

311

Disposals

(240)

(240)

Amortisation

(33)

(33)

Foreign exchange movements

Β 

At 31 December 2021

3

─────

41

═════

3

─────

41

═════

Β 

Lease liabilities

Β 

Β 

Land and

buildings

Β£'000

Total

Β£'000

At 1 January 2021

391

391

Interest expense

4

4

Lease payments

(345)

(345)

Foreign exchange movements

Β 

At 31 December 2021

(3)

─────

47

═════

(3)

─────

47

═════

Β 

Current liabilities

Β 

37

═════

Β 

37

═════

Β 

Non Current liabilities

Β 

10

═════

Β 

10

═════

Β 

15. Intangible assets

Β 

Group

Goodwill

Total

Β£'000

Β£'000

Cost

At 1 January 2021

1,684

1,684

Additions

-

-

Foreign exchange

-

-

────

─────

At 31 December 2021

1,684

1,684

════

═════

Amortisation

At 1 January 2021

1,684

1,684

Charge for the year

-

-

Impairment

-

-

Foreign exchange

-

-

────

─────

At 31 December 2021

1,684

1,684

════

═════

Net Book Value

At 31 December 2021

-

-

════

═════

At 31 December 2020

-

-

════

═════

Β 

Β 

16. Trade and other receivables

Β 

Group

Β 

Company

Β 

Β 

Current:

2021

Β£'000

2020

Β£'000

Restated

2021 2020

Β£'000 Β£'000

Restated

Trade receivables

-

83

- -

Amounts owed by group undertakings

-

-

1,374 1,310

Provision for impairment

-

-

(1,374) (609)

Amounts owed by associated undertakings

-

14

- -

Directors' current accounts

63

63

57 58

Taxation

19

-

19 -

VAT

2

-

2 -

Prepayments and accrued income

9

109

- 4

Other debtors

24

────

117

════

41

────

310

════

- -

──── ────

78 763

════ ════

Β 

17. Cash and cash equivalents

Β 

Β 

Group

Β 

Β 

Company

2021

Β£'000

2020

Β£'000

2021 2020

Β£'000 Β£'000

Bank accounts

209

════

91

════

193 44

════ ════

Β 

18. Called up share capital

Group and company

Β 

Authorised share capital:

2021

Β£'000

2020

Β£'000

195,000,000 Deferred shares of 4.8p each

9,360

9,360

67,052,306 Deferred shares of 4p each

2,682

2,682

300,000,000 Ordinary shares of 0.1p each

300

300

2,700,000,000 Deferred shares of 0.1p each

Β 

Β 

Allotted, called up and fully paid:

2,700

─────

15,042

═════

2,700

───── 15,042

═════

147,745,300 Deferred shares of 4.8p each

7,092

7,092

67,052,306 Deferred shares of 4p each

2,682

2,682

233,000,000 Ordinary shares of 0.1p each

233

218

1,225,628,316 Deferred shares of 0.1p each

1,225

─────

11,232

═════

1,226

───── 11,218

═════

The ordinary shares have both voting rights and the right to dividends. The deferred shares have no rights to dividends and no voting rights.

On a winding up the holders of the deferred shares of 4.8p each shall be entitled to receive 1p per share after the repayment of all amounts payable to the holders of any other class of share and the payment of Β£5,000 on each ordinary share for the time being in issue. On a winding up the holders of deferred shares of 0.1p each shall be entitled to receive 0.1p per share after the payment of Β£5,000 on each ordinary share for the time being in issue but shall not confer the right to participate in any surplus.

The deferred shares of 4.8p each are redeemable at the company's option any time at a price of 1p for each of the deferred shares held by any member. The deferred shares of 0.1p each are transferable at the company's option at any time to any person at a total price of 1p for all of the shares held by the shareholder. The deferred shares of 0.1p each are redeemable or cancellable at the company's option at any time at a total price of 1p for all of the shares held by a shareholder.

As the deferred shares rank behind the ordinary shares, they are recognised as equity.

Managing capital

The Group considers only the allotted share capital set out above to be the capital of the group. There are no financial liabilities considered to be part of the capital, and no components of equity excluded from it.

The Group's objectives when managing capital are:

- To safeguard the entity's ability to continue as a going concern, so that it can continue to provide returns for shareholders and benefits for other stakeholders.

- To provide an adequate return to shareholders by pricing products and services at an appropriate level taking into account the level of risk.

The Group sets an amount of capital in proportion to risk. The Group manages the capital structure and makes adjustments to it in the light of changes in economic conditions and risk characteristics of the underlying assets.

The entity is not subject to any externally imposed capital requirements.

Share Issue

On 15 September 2021 the company issued 13,126,051 ordinary shares for a total consideration amounting to Β£377,883.

On 15 October 2021 the company issued 1,106,474 ordinary shares for a total consideration amounting to Β£30,981.

Β 

19. Reserves

Β 

Group

Retained

earnings

Share

premium

Other

reserves

Translation

reserve

Convertible

debenture

Totals

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

At 1 January 2021

(39,820)

3,146

15,384

(199)

5,145

(16,344)

Total comprehensive

income for the year

Β 

(2,576)

Β 

-

Β 

-

Β 

(13)

Β 

-

Β 

(2,589)

Premium on issue of share capital

Β 

-

Β 

394

Β 

-

Β 

-

Β 

-

Β 

394

Debenture derecognition

-

-

-

-

(5,145)

(5,145)

Debenture re-

recognition

453

-

-

-

4,692

5,145

─────

────

─────

─────

────

─────

At 31 December 2021

(41,943)

3,540

15,384

(212)

4,692

(18,539)

═════

════

═════

═════

════

═════

Β 

Company

Β 

Retained earnings

Β 

Share premium

Β 

Other reserves

Β 

Convertible debenture

Β 

Totals

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

At 1 January 2021

(52,320)

3,146

30,938

5,145

(13,091)

Loss for the year

(3,372)

-

-

-

(3,372)

Premium on issue of share capital

Β 

-

Β 

394

Β 

-

Β 

-

Β 

394

Debenture derecognition

Β 

-

Β 

-

Β 

-

Β 

(5,145)

Β 

(5,145)

Debenture re-

recognition

Β 

453

Β 

-

Β 

-

Β 

4,692

Β 

5,145

─────

────

─────

────

─────

At 31 December 2021

(55,239)

3,540

30,938

4,692

(16,069)

═════

════

═════

════

═════

Β 

Other reserves of the Group consist of a capital redemption reserve of Β£1.92m (2020: Β£1.92m), a non-distributable capital reserve of Β£3.33m (2020: Β£3.33m) and a special reserve of Β£10.13m (2020: Β£10.13m).

Β 

Convertible debenture of the group consists of the equity portion of convertible loan debentures of Β£4.692m (2020: Β£5.145m).

Β 

Other reserves of the company consist of a capital redemption reserve of Β£1.92m (2020: Β£1.92m) and a special reserve of Β£29.02m (2020: Β£29.02m).

Β 

Convertible debenture of the company consists of the equity portion of convertible loan debentures of Β£4.692m (2020: Β£5.145m).

Β 

20. Trade and other payables

Β 

Group

Β 

Company

Β 

Β 

Current:

2021

Β£'000

2020

Β£'000

Restated

2021 2020

Β£'000 Β£'000

Restated

Trade payables

293

461

58 100

Amounts owed to associated undertakings

2,335

2,226

- -

Amounts owed to group undertakings

-

-

561 268

Taxation

19

-

19 -

Other creditors

388

376

23 23

Accruals and deferred income

280

────

3,315

════

345

──── 3,408

════

253 160

──── ────

914 551

════ ════

21. Financial liabilities - borrowings

Β 

Group

Β 

Company

Β 

Β 

Current:

2021

Β£'000

2020

Β£'000

Restated

2021 2020

Β£'000 Β£'000

Restated

Debentures

346

222

346 222

Bank loans

48

3

48 3

Other loans

129

────

523

════

-

────

225

════

- -

──── ────

394 225

════ ════

Non-current: Debentures

Β 

1,256

Β 

846

Β 

1,256 846

Bank loans

-

47

- 47

Other loans

1,747

────

3,003

════

1,658

──── 2,551

════

1,747 1,658

──── ────

3,003 2,551

════ ════

Terms and debt repayment schedule:

Β 

1 year

Group

or less

Β£'000

2-5 years Totals

Β£'000 Β£'000

Debentures

346

1,256 1,602

Bank loans

48

- 48

Other loans

Β 

Β 

Β 

Company

129

────

523

════ 1 year or less

Β£'000

1,747 1,876

──── ────

3,003 3,526

════ ════

Β 

2-5 years Totals

Β£'000 Β£'000

Debentures

346

1,256 1,602

Bank loans

48

- 48

Other loans

-

────

394

════

1,747 1,747

──── ────

3,003 3,397

════ ════

Ross Group Plc & Subsidiaries

Notes to the Consolidated Financial Statements For the year ended 31 December 2021

Β 

Β 

21. Financial liabilities - borrowings - continued Convertible loan debenture

The parent entity issued two convertible loan debenture (CLD) on 27 September 2018 for Β£4,010k and Β£2,062k at a coupon rate of 5%.

Β 

The notes are convertible into Ordinary shares of the parent entity in three years after the date of issue.

At the Annual General Meeting on 31 December 2020 it was agreed to extend the conversion period to 26 September 2022.

At the Annual General Meeting on 31 December 2021 it was agreed to extend the conversion period to 26 September 2025.

At each of the dates of modification the value of the conversion rights were derecognised in the financial statements and a new valuation of the conversion rights was recognised.

The convertible loan debenture will give right to a percentage of the issued share capital of the parent company at the date of conversion. Each tranche of Β£1 Million CLD owed by the long- term loan holders correspond to 4.925% of the issued share capital at the date of conversion, resulting in a fixed percentage of the issued share capital of the company to be allocated to the loan holders regardless of the value/amount of the share capital of the company.

Β 

2021

Β£'000

2020

Β£'000

Restated

Face value of notes issued

6,072

6,072

Value of conversion rights

4,692

────

5,145

────

1,380

927

Interest expense *

222

141

Interest paid

Β 

Total liability element

-

────

1,602

════

-

──── 1,068

════

Β 

*Interest is calculated by applying the effective interest rate of 5% to the total loan note amount.

Β 

The initial fair value of the liability portion of the debenture was determined using a market interest rate for an equivalent non-convertible debenture at the issue date. The liability is subsequently recognised on an amortised cost basis until extinguished on conversion or maturity of the bonds.

Β 

Β 

22. Financial instruments

Β 

The Group uses financial instruments, comprising borrowings, cash, liquid resources and various items, such as trade debtors, trade creditors etc., that arise directly from its operations. The main purpose of these financial instruments is to raise finance for the group's operations.

Β 

The Group did not enter into derivatives transactions such as interest rate swaps, forward rate agreements and forward foreign currency contracts.

Β 

The Board of the Group considers that the interest rate risk, liquidity risk and foreign currency risks arising from the Group financial instruments are low. However, it reviews policies for managing each of these risks and they are summarised below. These policies have remained unchanged from previous periods.

Β 

It is and has been throughout the year under review, the group policy that no trading in financial instruments shall be undertaken.

Β 

Short-term debtors and creditors

Short-term debtors and creditors have been excluded from all the following disclosures, other than the currency risk disclosures.

Β 

Interest rate risk

The Group finances its operations through a mixture of borrowings. It relies on loans from its shareholders to ensure sufficient liquidity is available to meet foreseeable needs.

Β 

Maturity of financial liabilities

For the Group financial liabilities analysis at 31 December 2021 see note 21.

Β 

Currency risk

The Group does have foreign investments held in foreign currencies.

Β 

The Group's exposure to translation and transaction exchange risk is considered to be low by the board.

Β 

There was no income in the current year. 100% of the Group's worldwide income in the prior year was invoiced in US Dollars and has been settled in 2021. As a result the board does not consider there is a need for Group policy to manage the currency risk as it considers the risk to be low.

Β 

Fair values

The board considers that the fair values of the Group's borrowings are equal to their book values.

Β 

Β 

23. Related party disclosures Group

The Group had the following balances with related parties at the year end.

Β 

31/12/21 31/12/20

Β£'000 Β£'000

Β 

Receivables

Barry Pettitt 63 63

════ ════

Β 

Barry Pettitt, the Chairman and Chief Executive Officer of Ross Group Plc, owns Lynchwood Nominees (previously Prime Growth Enterprises Limited). Lynchwood Nominees owns 12% of the ordinary share capital in Ross Group Plc.

Β 

Β 

Company

Β 

At the year end Ross Group Plc had the following outstanding balances with its related parties:

Β 

31/12/21

Β£'000

31/12/20

Β£'000

Receivables

Barry Pettitt

Β 

57

Β 

58

Mari Signum Dragon Drying - MS LLC

-

14

Prometheus Progeniture Genetics Technologies Limited LLC

-

164

Ross Group Plc Inc

-

523

Ross Diversified

-

────

57

════

-

────

759

════

Payables

Mari Signum Mid-Atlantic II LLC

Β 

268

Β 

268

Mari Signum Dragon Drying - MS LLC

293

────

561

════

-

────

268

════

Β 

Ross Group Plc owns 100% of the capital of Ross Diversified Trading Limited, Mari Signum Limited, Mari Signum Dragon Drying - MS LLC, Mari Signum Mid-Atlantic II LLC, Prometheus Progeniture Genetics Technologies Limited LLC and Ross Group Plc Inc.

Β 

Barry Pettitt, the Chairman and Chief Executive Officer of Ross Group Plc, owns Lynchwood Nominees (previously Prime Growth Enterprises Limited). Lynchwood Nominees owns 12% of the ordinary share capital in Ross Group plc.

Β 

24. Ultimate controlling party

Β 

The directors consider that there is no ultimate controlling party of Ross Group Plc and subsidiaries for 2021: however, Barry Pettitt, by virtue of his position as CEO within the Group and his 12% shareholding, exerts a significant influence.

Β 

Β 

25. Reconciliation of movements in reserves

31/12/21 31/12/20

Group Β£'000 Β£'000

Restated

Β 

(Loss) for the financial year (2,589) (1,334) Issue of share capital 408 -

Derecognition of conversion rights (5,145) (5,354)

Value of conversion rights 4,692 5,145

Reserves adjustment of convertible debenture 453 209

──── ────

Net addition to reserves (2,181) (1,334)

Opening reserves (5,126) (3,792)

──── ────

Closing reserves (7,307) (5,126)

════ ════

Β 

Β 

31/12/21 31/12/20

Company Β£'000 Β£'000

Restated

Β 

(Loss) for the financial year (3,372) (556) Issue of share capital 408 -

Derecognition of conversion rights (5,145) (5,354)

Value of conversion rights 4,692 5,145

Reserves adjustment of convertible debenture 453 209

──── ────

Net addition to reserves (2,964) (556)

Opening reserves (1,873) (1,317)

──── ────

Closing reserves (4,837) (1,873)

════ ════

Β 

26. Provisions

Β 

31/12/21 31/12/20

Β£'000 Β£'000

Restated

Β 

Balance brought forward - -

Movement in the year 813 -

──── ────

Balance carried forward 813 -

════ ════

Β 

The group is involved as defendants in a multi-party lawsuit brought in the United States of America, a provision has been included in the financial statements to provide for any potential claim and legal expenses.

Β 

27. Prior Year Adjustment

Β 

Group

2020 Audited

Correction of prior year

2020 Restated

Audited

Impact

Restated

Β£'000

Β£'000

Β£'000

Assets

Inventories

-

-

-

Trade and other receivables

269

41

310

Cash and cash equivalents

91

-

91

Investments

424

-

424

Property, plant and equipment

355

(42)

313

Right of use assets

311

-

311

Intangible assets

-

-

-

────

────

────

Total Assets

1,450

(1)

1,449

════

════

════

Β 

Liabilities and equity

Lease liabilities (non-current)

183

-

183

Financial liabilities (non-current)

1,705

(846)

2,551

Trade and other payables

3,408

-

3,408

Lease liabilities (current)

208

-

208

Financial liabilities (current)

957

732

225

────

────

────

Total Liabilities

6,461

(114)

6,575

════

════

════

Equity attributable to equity holders of parent

Shareholders' equity

11,218

-

11,218

Share premium

3,146

-

3,146

Others reserves

15,384

-

15,384

Convertible debentures

5,815

670

5,145

Translation reserve

-

(199)

(199)

Retained earnings

(40,574)

754

(39,820)

────

────

────

Total Equity

(5,011)

115

(5,126)

════

════

════

Total Liabilities and Equity

1,450

1,449

════

════

Β 

27. Prior Year Adjustment - continued

Β 

Company

2020 Audited

Correction of prior year

2020 Restated

Audited

Impact

Restated

Β£'000

Β£'000

Β£'000

Assets

Trade and other receivables

763

-

763

Cash and cash equivalents

44

-

44

Investments

627

-

627

Property, plant and equipment

20

-

20

────

────

────

Total Assets

1,454

-

1,454

════

════

════

Β 

Liabilities and equity

Financial liabilities (non-current)

1,705

(846)

2,551

Trade and other payables

551

-

551

Financial liabilities (current)

957

732

225

────

────

────

Total Liabilities

3,213

(114)

3,327

════

════

════

Equity attributable to equity holders of parent

Shareholders' equity

11,218

-

11,218

Share premium

3,146

-

3,146

Others reserves

30,938

-

30,938

Convertible debentures

5,815

670

5,145

Retained earnings

(52,876)

(556)

(52,320)

────

────

────

Total Equity

(1,759)

114

(1,873)

════

════

════

Total Liabilities and Equity

1,454

1,454

════

════

Β 

27. Prior Year Adjustment - continued

Β 

Consolidated Income Statement

2020

Audited

Correction of prior year

2020 Restated

Audited

Impact

Restated

Β£'000

Β£'000

Β£'000

Β 

Revenue

Β 

43

Β 

-

Β 

43

Production expenses

(39)

-

(39)

Other operating income

127

8

135

Administrative expenses

(1,056)

162

(894)

Finance income

1

-

1

Finance expense

(539)

48

(491)

Income tax

-

-

-

────

────

────

Loss for the year

(1,463)

218

(1,245)

════

════

════

Total comprehensive income

(1,399)

65

(1,334)

════

════

════

Earnings per share (basic)

(0.67)

0.10

(0.57)

════

════

════

Earnings per share (diluted)

(0.67)

0.23

(0.44)

════

════

════

Β 

Company Income Statement

2020 Audited

Correction of prior year

2020 Restated

Audited

Impact

Restated

Β£'000

Β£'000

Β£'000

Β 

Revenue

Β 

-

Β 

-

Β 

-

Other operating income

30

-

30

Administrative expenses

(220)

-

(220)

Finance expense

(421)

55

(366)

Income tax

-

-

-

────

────

────

Loss for the year

(611)

55

(556)

════

════

════

Β 

27. Prior Year Adjustment - continued

Β 

The Company and Group has restated the balance sheet, statement of other comprehensive income, statement of financial position, and statement of changes in equity. This is due errors in the accounting treatment for convertible loan debentures, foreign exchange translation and recognition of a Group asset which was not owned by the Group. This has been considered as a prior year error and has been corrected in accordance with IAS 8 (Accounting Policies, Changes in Accounting Estimates and Errors). The overall impact of this restatement is disclosed in the note above.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FR PPUBPBUPPGAU
12
Date   Source Headline
2nd Nov 20239:23 amRNSTemporary Suspension
24th Mar 20234:16 pmRNSHalf-year Report
28th Feb 202310:58 amRNSNew Accounting Ref Date
25th Nov 20222:43 pmRNSIssue of Equity
24th Nov 20229:05 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension
23rd Nov 20224:15 pmRNSRenaming of subsidiary company
30th Sep 20224:12 pmRNSHalf-year Report
20th Sep 20224:43 pmRNSAnnual Financial Report
1st Jul 20227:30 amRNSTemporary Suspension-ROSS GROUP PLC
29th Jun 20223:19 pmRNSDelay on publication of the annual report
8th Jun 202212:54 pmRNSIssue of Equity
14th Oct 20213:52 pmRNSIssue of Equity
15th Sep 20212:32 pmRNSHalf-year Report
10th Sep 202111:48 amRNSIssue of Equity
10th Sep 202110:14 amRNSIssue of Equity
27th Jul 20214:41 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20213:31 pmRNSFinal Results
16th Feb 202111:05 amRNSSecond Price Monitoring Extn
16th Feb 202111:00 amRNSPrice Monitoring Extension
15th Feb 20214:40 pmRNSSecond Price Monitoring Extn
15th Feb 20214:35 pmRNSPrice Monitoring Extension
15th Feb 20212:05 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 202111:05 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 20219:05 amRNSSecond Price Monitoring Extn
12th Feb 20219:00 amRNSPrice Monitoring Extension
8th Jan 20215:00 pmRNSDirectorate Change
29th Sep 202010:48 amRNSHalf-year Report
26th Jun 20202:47 pmRNSAnnual Financial Report
27th Dec 20197:00 amRNSDirectorate Change
22nd Oct 20197:00 amRNSDirectorate Change
29th Aug 20193:12 pmRNSHalf-year Report
29th Apr 20194:48 pmRNSAnnual Financial Report
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:35 pmRNSPrice Monitoring Extension
24th Jan 201910:06 amRNSIssue of Equity
12th Oct 20187:00 amRNSAdditional Listing
27th Sep 20187:00 amRNSProposed Acquisition of Archipelago Aquaculture
31st Aug 201811:40 amRNSHalf-year Report
24th Apr 20183:13 pmRNSAnnual Financial Report
30th Aug 20179:29 amRNSHalf-year Report
26th Apr 20173:54 pmRNSRoss Annual Results
30th Aug 201611:45 amRNSHalf-year Report
28th Apr 20165:32 pmRNSAnnual Financial Report
8th Oct 201511:28 amRNSNotice of AGM
27th Aug 201510:51 amRNSHalf Yearly Report
30th Apr 20153:22 pmRNSAnnual Financial Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.